Delaware |
7370 |
98-1546280 | ||
(State or other Jurisdiction of Incorporation Or Organization) |
(Primary Standard Industrial Classification Code Number) |
(I.R.S. Employer Identification Number) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
☒ |
Smaller reporting company | |||||
Emerging growth company |
| ||||||||
Title of Each Class of Securities to be Registered |
Amount to be Registered(1) |
Proposed Maximum Offering Price |
Proposed Maximum Aggregate Offering Price |
Amount of Registration Fee | ||||
Primary Offering: |
||||||||
Common stock, par value $0.0001 per share(2) |
35,100,000 |
$ 11.50(3) |
$403,650,000.00(3) |
$44,038.22 | ||||
Secondary Offering: |
||||||||
Common stock, par value $0.0001 per share(4) |
569,506,621 |
$ 9.74(5) |
$5,546,994,489.54(5) |
$605,177.10 | ||||
Warrants to purchase Common stock, par value $0.0001 per share(6) |
21,300,000 |
$ — |
$— |
—(7) | ||||
Total |
$5,950,644,489.54 |
$649,215.32 (8) | ||||||
| ||||||||
|
(1) |
Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “ Securities Act |
(2) |
Consists of: (i) 13,800,000 shares of Common Stock that may be issued upon exercise of the Public Warrants (as defined below) based on the number of public warrants outstanding as of August 20, 2021; (ii) 15,800,000 shares of Common Stock that may be issued upon exercise of the Private Placement Warrants (as defined below); (iii) 2,000,000 shares of Common Stock that may be issued upon exercise of the Working Capital Warrants; and (iv) 3,500,000 shares of Common Stock that may be issued upon exercise of the Forward Purchase Warrants (as defined below). |
(3) |
Calculated pursuant to Rule 457(g) under the Securities Act based on the fixed conversion or exercise price per share of the New CCC Common Stock issuable upon exercise of the Warrants (as defined below). |
(4) |
Consists of the following shares of Common Stock registered for resale by the Selling Holders (as defined below): (i) 15,800,000 shares of Common Stock underlying the Private Placement Warrants; (ii) 2,000,000 shares of Common Stock underlying the Working Capital Warrants; (iii) 3,500,000 shares of Common Stock underlying the Forward Purchase Warrants; (iv) 498,456,621 shares of Common Stock issued in the Business Combination (as defined below); (v) 17,250,000 shares of Common Stock originally issued to the Sponsor (as defined below); (vi) 15,000,000 shares of Common Stock issued in the PIPE Financing (as defined below); and (vii) 17,500,000 Forward Purchase Shares (as defined below). |
(5) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) of the Securities Act, based upon the average of the high and low selling prices of the Common Stock on August 20, 2021 as reported on the New York Stock Exchange, under the symbol “CCCS”. |
(6) |
Consists of: (i) 15,800,000 Private Placement Warrants; (ii) 2,000,000 Working Capital Warrants and (iii) 3,500,000 Forward Purchase Warrants. |
(7) |
Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required with respect to the Warrants. |
(8) |
Amount previously paid. |
ii | ||||
1 | ||||
12 | ||||
15 | ||||
49 | ||||
50 | ||||
51 | ||||
63 | ||||
70 | ||||
84 | ||||
87 | ||||
94 | ||||
97 | ||||
112 | ||||
143 | ||||
159 | ||||
168 | ||||
169 | ||||
173 | ||||
178 | ||||
178 | ||||
178 | ||||
178 | ||||
F-1 |
• | the ability to maintain the listing of the New CCC Common Stock and the warrants on the NYSE, and the potential liquidity and trading of such securities; |
• | the risk that the Business Combination disrupts our current plans and operations; |
• | costs related to the Business Combination; |
• | changes in applicable laws or regulations; |
• | our ability to raise financing in the future; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business; |
• | our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; |
• | our financial performance; |
• | our ability to expand or maintain our existing customer base; |
• | the effect of global economic conditions or political transitions on our customers and their ability to continue to purchase our products; and |
• | the effect of COVID-19 on the foregoing. |
• | Vehicle parts proliferation: |
• | Internal technology systems: |
• | Growing connected car capabilities: |
• | Transportation as a Service (“TaaS”) and other new business models: |
• | Advanced Driver Assistance Systems (“ADAS”) and diagnostics systems: |
• | Growing our customer base: |
• | Deepening relationships with existing customers: up-selling customers based on package and feature upgrades. We intend to build upon strong customer relationships and access to key customer decision makers to increase software adoption and usage. |
• | Expanding the breadth of our solutions: one-third of our collision repair customers have already adopted this subscription package solution. We intend to continuously launch new solutions to improve value delivery, and expand the breadth of our capabilities across the P&C insurance landscape. |
• | Broadening our network ecosystem: |
• | Growing our geographic footprint: |
• | Pursuing acquisitions: |
• | CCC Workflow: end-to-end two-way text communications. Our workflow solutions leverage a sophisticated rules engine to customize routing for escalations, review, and approval processes. Our network management capability powers insurance DRPs, enabling insurers to seamlessly connect and collaborate with repair facilities and other companies to provide accurate and timely information about a claim flow from the right party at the right time. |
• | CCC Estimating: best-in-class AI-powered estimating solution which uses AI machine learning and estimating logic to predict repair requirements, suggest estimate lines, and generate fast baseline estimates. Our estimating solutions accelerate auto physical damage estimation to reduce costs and cycle time for our customers. |
• | CCC Total Loss: |
• | CCC AI and Analytics: AI-enabled solutions. All of our core software offerings are supported by Analytics solutions that allow our customers to benchmark and manage their business performance across key performance indicators. |
• | CCC Casualty: |
configurable experience to help insurers make timely, consistent payments across bill types, and provide analytics dashboards to visualize trends and industry benchmarks. |
• | CCC Estimating: |
• | CCC Network Management: |
• | CCC Repair Workflow: Customer-to-shop |
• | CCC Repair Quality: |
• | CCC Parts Solutions: |
• | CCC Automotive Manufacturer Solutions up-to-date |
• | CCC Lender Solutions |
• | presenting only two years of audited financial statements and only two years of selected financial data; |
• | an exemption from compliance with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act; |
• | reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements, and registration statements; and |
• | exemptions from the requirements of holding nonbinding advisory votes on executive compensation or golden parachute arrangements. |
Shares of New CCC Common Stock to be issued upon exercise of all Public Warrants, Private Placement Warrants and Forward Purchase Units | 35,100,000 shares. | |
Shares of New CCC Common Stock outstanding prior to the exercise of all Public Warrants, Private Placement Warrants and Forward Purchase Warrants | 603,170,380 shares. | |
Use of proceeds | We will receive up to an aggregate of approximately $403.7 million from the exercise of all Public Warrants, Private Placement Warrants and Forward Purchase Units assuming the exercise in full of all such Warrants for cash. Unless we inform you otherwise in a prospectus supplement or free writing prospectus, we intend to use the net proceeds from the exercise of such Warrants for general corporate purposes, which may include acquisitions, strategic investments, or repayment of outstanding indebtedness. | |
Resale of Common Stock and Warrants |
||
Shares of Common Stock offered by the Selling Holders, consisting of (i) (i) 15,800,000 shares of Common Stock underlying the Private Placement Warrants; (ii) 2,000,000 shares of Common Stock underlying the Working Capital Warrants; (iii) 3,500,000 shares of Common Stock underlying the Forward Purchase Warrants; (iv) 498,456,621 shares of Common Stock issued in the Business Combination; (v) 17,250,000 shares of | 569,506,621 shares. |
Common Stock originally issued to the Sponsor, (vi) 15,000,000 shares of Common Stock issued in the PIPE Financing; and (vii) 17,500,000 Forward Purchase Shares | ||
Warrants offered by the Selling Holders (consisting of 15,800,000 Private Placement Warrants, 2,000,000 Working Capital Warrants and 3,500,000 Forward Purchase Units) | 21,300,000 warrants. | |
Exercise price | $11.50 per share, subject to adjustment as described herein. | |
Redemption | The Warrants are redeemable in certain circumstances. See “Description of Securities—Company Warrants” for further discussion. | |
Use of proceeds | We will not receive any proceeds from the sale of the Common Stock and Warrants to be offered by the Selling Holders. With respect to shares of Common Stock underlying the Warrants, we will not receive any proceeds from such shares except with respect to amounts received by us upon exercise of such Warrants to the extent such Warrants are exercised for cash. | |
Lock-up agreements |
Certain of our stockholders are subject to certain restrictions on transfer until the termination of applicable lock-up periods. See “Certain Relationships And Related Party Transactions—CCC Related Person Transactions” for further discussion. | |
NYSE Ticker Symbols | Common Stock: “CCCS” Public warrants: “CCCS WS” |
• | A substantial portion of our revenue is derived from a relatively small number of customers in the P&C insurance and automotive collision industries, and the loss of any of these customers, or a significant revenue reduction from any of these customers, could materially harm our business, results of operations and financial condition; |
• | Our business depends on our brand, and if we fail to develop, maintain, and enhance our brand and reputation cost-effectively, our business and financial condition may be adversely affected; |
• | Our revenue growth rate depends on existing customers renewing and upgrading their SaaS software subscriptions for our solutions. A decline in our customer renewals and expansions could adversely impact our future results of operations; |
• | Our growth strategy depends on continued investment in and delivery of innovative SaaS solutions. If we are unsuccessful in delivering innovative SaaS solutions, it could adversely impact our results of operations and financial condition; |
• | Public health outbreaks, epidemics or pandemics, including the global COVID-19 pandemic, could harm our business and results of operations; |
• | Macroeconomic factors impacting the principal industries we serve could adversely affect our product adoption, usage, or average selling prices; |
• | If we are unable to develop, introduce and market new and enhanced versions of our solutions and products, we may be put at a competitive disadvantage and our operating results could be adversely affected; |
• | Our sales and implementation cycles can be lengthy and variable, depend upon factors outside our control, and could cause us to expend significant time and resources prior to generating revenue; |
• | If we are unable to develop new markets or sell our solutions into these new and existing markets, our revenue will not grow as expected; |
• | Sales to customers or operations outside the United States may expose us to risks inherent in international sales; |
• | Changes in China’s economic, political or social conditions or government policies, as well as the corruption risks presented by operating in China, could have an adverse effect on our efforts to expand our business in China. |
• | We rely on data, technology and intellectual property of third parties and our solutions rely on information generated by third parties and any interruption of our access to such information, technology, and intellectual property could materially harm our operating results; |
• | Failure to protect our intellectual property could adversely impact our business and results of operations; |
• | Our solutions or products or our third-party cloud providers have experienced in the past, and could experience in the future, data security breaches, which could adversely impact our reputation, business, and ongoing operations; |
• | Some of our services and technologies use “open source” software, which may restrict how we use or distribute our services or require that we release the source code of certain products subject to those licenses; and |
• | We evaluate our capital structure from time to time and may seek to repurchase our securities, refinance our indebtedness or raise debt or equity to finance our operations. However, we may not be able to do so when desired on favorable terms, if at all, or without dilution to our stockholders and we may not realize the anticipated benefits of these transactions; and |
• | other risks and uncertainties indicated in this prospectus, including those set forth under the section entitled “Risk Factors.” |
• | compliance with multiple conflicting and changing governmental laws and regulations, including employment, tax, money transmission, privacy, and data protection laws and regulations; |
• | laws and business practices favoring local competitors; |
• | new and different sources of competition; |
• | securing new integrations for international technology platforms; |
• | localization of our solutions, including translation into foreign languages, obtaining and maintaining local content, and customer care in such languages; |
• | treatment of revenue from international sources and changes to tax rules, including being subject to foreign tax laws and liability for paying withholding or other taxes in foreign jurisdictions; |
• | fluctuation of foreign currency exchange rates; |
• | different pricing environments; |
• | restrictions on the transfer of funds; |
• | difficulties in staffing and managing foreign operations; |
• | availability of reliable internet connectivity in areas targeted for expansion; |
• | different or lesser protection of our intellectual property; |
• | longer sales cycles; |
• | natural disasters, acts of war, terrorism, pandemics, or security breaches; |
• | import and export license requirements, tariffs, taxes and other trade barriers; |
• | compliance with sanctions laws and regulations, including those administered by the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury; |
• | the burdens and costs of complying with a wide variety of foreign laws and legal standards, including the General Data Protection Regulation (EU 2016/679) (“GDPR”) in the European Union (“EU”); |
• | impact of Brexit on operations and growth of business in the European Union; |
• | compliance with various anti-bribery and anti-corruption laws such as the U.S. Foreign Corrupt Practices Act (“FCPA”); |
• | regional or national economic and political conditions; and |
• | pressure on the creditworthiness of sovereign nations resulting from liquidity issues or political actions. |
• | changes in the industries in which New CCC and its customers operate; |
• | variations in its operating performance and the performance of its competitors in general; |
• | material and adverse impact of the COVID-19 pandemic on the markets and the broader global economy; |
• | actual or anticipated fluctuations in New CCC’s quarterly or annual operating results; |
• | publication of research reports by securities analysts about New CCC or its competitors or its industry; |
• | the public’s reaction to New CCC’s press releases, its other public announcements and its filings with the SEC; |
• | New CCC’s failure or the failure of its competitors to meet analysts’ projections or guidance that New CCC or its competitors may give to the market; |
• | additions and departures of key personnel; |
• | changes in laws and regulations affecting its business; |
• | commencement of, or involvement in, litigation involving New CCC; |
• | changes in New CCC’s capital structure, such as future issuances of securities or the incurrence of additional debt; |
• | the volume of shares of New CCC Common Stock available for public sale; and |
• | general economic and political conditions such as recessions, interest rates, fuel prices, foreign currency fluctuations, international tariffs, social, political and economic risks and acts of war or terrorism. |
• | the ability of our Board to issue shares of preferred stock, including “blank check” preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; |
• | the limitation of the liability of, and the indemnification of, our directors and officers; |
• | removal of the ability of our stockholders to take action by written consent in lieu of a meeting unless investment fund(s) affiliated with or managed by Advent International Corp. or any of its |
affiliates, or any successor, transferee or affiliate thereof, beneficially own a majority of the voting power of all of the then-outstanding shares of our capital stock entitled to vote on such action, or such action has been recommended or approved pursuant to a resolution approved by the affirmative vote of all of the directors then in office; |
• | the requirement that a special meeting of stockholders may be called only by a majority of our entire Board, which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors; |
• | controlling the procedures for the conduct and scheduling of board of directors and stockholder meetings; |
• | the ability of the our Board to amend the bylaws, which may allow our Board to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and |
• | advance notice procedures with which stockholders must comply to nominate candidates to our Board or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board, and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of CCC. |
• | making it more difficult for us to make payments on the First Lien Credit Facilities and our other obligations; |
• | increasing our vulnerability to general economic and market conditions and to changes in the industries in which we compete; |
• | requiring a substantial portion of cash flow from operations to be dedicated to the payment of principal and interest on our indebtedness, thereby reducing our ability to use our cash flow to fund our operations, future working capital, capital expenditures, investments or acquisitions, future strategic business opportunities, or other general corporate requirements; |
• | restricting us from making acquisitions or causing us to make divestitures or similar transactions; |
• | limiting our ability to obtain additional financing for working capital, capital expenditures, debt service requirements, investments, acquisitions, and general corporate or other purposes; |
• | limiting our ability to adjust to changing market conditions and placing us at a competitive disadvantage compared to our competitors who are less highly leveraged; and |
• | increasing our cost of borrowing. |
• | incur additional indebtedness; |
• | create or incur liens; |
• | pay dividends and distributions on, or purchase, redeem, defease, or otherwise acquire or retire for value, our capital stock; |
• | make repayments or repurchases of debt that is contractually subordinated with respect to right of payment or security; |
• | create negative pledges with respect to the First Lien Credit Facilities or restrictions on the payment of dividends or payment of other amounts owed from subsidiaries; |
• | make acquisitions, investments, loans (including guarantees), advance or capital contributions; |
• | engage in consolidations, amalgamations, mergers, liquidations, dissolutions, dispositions and/or sell, transfer, or otherwise dispose of assets, including capital stock of subsidiaries; |
• | enter into certain sale and leaseback transactions; |
• | engage in certain transactions with affiliates; |
• | change our material lines of business; |
• | modify certain documents governing certain debt that is subordinated with respect to right of payment; |
• | change our fiscal year; and |
• | conduct material operations at Cypress Intermediate Holdings II, Inc. |
• | limited in how we conduct our business; |
• | unable to raise additional debt or equity financing to operate during general economic or business downturns; |
• | unable to compete effectively or to take advantage of new business opportunities; and/or |
• | limited in our ability to grow in accordance with, or otherwise pursue, our business strategy. |
Dragoneer (Historical) |
CCC (Historical) |
Pro Forma Adjustments |
Pro Forma |
|||||||||||||||
ASSETS |
||||||||||||||||||
Current assets: |
||||||||||||||||||
Cash and cash equivalents |
$ | 1,442 | $ | 58,506 | $ | 479,913 | (b.1) | $ | 140,473 | |||||||||
150,000 | (b.2) | |||||||||||||||||
175,000 | (c) | |||||||||||||||||
(24,150 | ) | (d) | ||||||||||||||||
(14,234 | ) | (d) | ||||||||||||||||
(7,210 | ) | (d) | ||||||||||||||||
(2 | ) | (l) | ||||||||||||||||
(134,570 | ) | (g) | ||||||||||||||||
(10,218 | ) | (i) | ||||||||||||||||
(9,004 | ) | (j) | ||||||||||||||||
(525,000 | ) | (n) | ||||||||||||||||
Accounts and notes receivable, net of allowances of $4,218 for June 30, 2021 |
— | 81,817 | — | 81,817 | ||||||||||||||
Income taxes receivable |
— | 1,244 | — | 1,244 | ||||||||||||||
Deferred contract costs |
— | 12,681 | — | 12,681 | ||||||||||||||
Prepaid expenses |
253 | — | (253 | ) | (k) | — | ||||||||||||
Other current assets |
— | 33,524 | 253 | (k) | 30,826 | |||||||||||||
(2,951 | ) | (d.1) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total current assets |
1,695 | 187,772 | 77,574 | 267,041 | ||||||||||||||
Investments held in Trust Account |
690,022 | — | (210,109 | ) | (a.1) | — | ||||||||||||
(479,913 | ) | (b.1) | ||||||||||||||||
Software, equipment and property—net |
— | 108,640 | — | 108,640 | ||||||||||||||
Operating lease assets |
— | 41,859 | — | 41,859 | ||||||||||||||
Intangible assets—net |
— | 1,262,608 | — | 1,262,608 | ||||||||||||||
Goodwill |
— | 1,466,884 | — | 1,466,884 | ||||||||||||||
Deferred financing fees, revolver—net |
— | 598 | — | 598 | ||||||||||||||
Long-term deferred contract costs |
— | 15,986 | — | 15,986 | ||||||||||||||
Equity method investment |
— | 10,228 | — | 10,228 | ||||||||||||||
Other assets |
— | 16,684 | — | 16,684 | ||||||||||||||
TOTAL ASSETS |
691,717 | 3,111,259 | (612,448 | ) | 3,190,528 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY |
||||||||||||||||||
Current liabilities: |
||||||||||||||||||
Accounts payable and accrued expenses |
— | 16,826 | — | 16,826 | ||||||||||||||
Accrued expenses |
5,086 | 58,393 | (4,300 | ) | (i) | 59,179 | ||||||||||||
Convertible note- related party, net of debt discount |
2,000 | — | (2,000 | ) | (m) | — | ||||||||||||
Advance from related party |
2 | — | (2 | ) | (l) | — | ||||||||||||
Income taxes payable |
— | 4,293 | — | 4,293 | ||||||||||||||
Current portion of long-term debt |
— | 13,846 | (13,846 | ) | (n) | — | ||||||||||||
Current portion of long-term licensing agreement—net of discount |
— | 2,620 | — | 2,620 | ||||||||||||||
Operating lease liabilities |
— | 9,546 | — | 9,546 | ||||||||||||||
Deferred revenues |
— | 28,824 | — | 28,824 | ||||||||||||||
Interest rate swap derivatives |
— | 11,993 | — | 11,993 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total current liabilities |
7,088 | 146,341 | (20,148 | ) | 133,281 | |||||||||||||
First Lien Term Loan—net of discount and fees |
— | 1,299,774 | (504,222 | ) | (n) | 795,552 | ||||||||||||
Deferred income taxes—net |
— | 311,280 | — | 311,280 | ||||||||||||||
Long-term licensing agreement—net of discounts |
— | 35,001 | — | 35,001 | ||||||||||||||
FPA liability |
6,831 | — | (6,831 | ) | (m) | — | ||||||||||||
Conversion option on working capital loan liability |
2,365 | — | (2,365 | ) | (m) | — | ||||||||||||
Warrant liabilities |
62,225 | — | 11,196 | (m) | 73,421 | |||||||||||||
Deferred underwriting fees payable |
24,150 | — | (24,150 | ) | (d) | — | ||||||||||||
Operating lease liabilities |
— | 41,338 | — | 41,338 | ||||||||||||||
Other liabilities |
— | 11,711 | — | 11,711 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total liabilities |
102,659 | 1,845,445 | (546,520 | ) | 1,401,584 | |||||||||||||
|
|
|
|
|
|
|
|
Dragoneer (Historical) |
CCC (Historical) |
Pro Forma Adjustments |
Pro Forma |
|||||||||||||||
Commitments and Contingencies |
||||||||||||||||||
Mezzanine Equity |
||||||||||||||||||
Redeemable non-controlling interest |
— | 14,179 | — | 14,179 | ||||||||||||||
Class A Ordinary Shares subject to possible redemption |
690,000 | — | (210,109 | ) | (a.1) | — | ||||||||||||
(479,891 | ) | (a.2) | ||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total Mezzanine equity |
690,000 | 14,179 | (690,000 | ) | 14,179 | |||||||||||||
Stockholders’ equity and Deficit |
||||||||||||||||||
Common Stock, $0.001 par value [New CCC Common Stock, $0.0001 par value] |
— | 1 | 5 | (a.2) | 67 | |||||||||||||
1 | (b.2) | |||||||||||||||||
2 | (c) | |||||||||||||||||
8 | (e) | |||||||||||||||||
50 | (f) | |||||||||||||||||
Preference shares, $0.0001 par value |
— | — | — | — | ||||||||||||||
Class A ordinary shares, $0.0001 par value |
— | — | — | (e) | — | |||||||||||||
Class B ordinary shares, $0.0001 par value |
2 | — | (2 | ) | (e) | — | ||||||||||||
Additional paid-in capital |
— | 1,517,123 | 479,886 | (a.2) | 2,503,527 | |||||||||||||
149,999 | (b.2) | |||||||||||||||||
174,998 | (c) | |||||||||||||||||
(10,053 | ) | (d) | ||||||||||||||||
(7,210 | ) | (d) | ||||||||||||||||
(100,950 | ) | (e) | ||||||||||||||||
(50 | ) | (f) | ||||||||||||||||
98,885 | (f1) | |||||||||||||||||
203,850 | (h) | |||||||||||||||||
(2,951 | ) | (d1) | ||||||||||||||||
Accumulated deficit |
(100,944 | ) | (265,189 | ) | (4,181 | ) | (d) | (728,529 | ) | |||||||||
100,944 | (e) | |||||||||||||||||
(98,885 | ) | (f1) | ||||||||||||||||
(134,570 | ) | (g) | ||||||||||||||||
(203,850 | ) | (h) | ||||||||||||||||
(5,918 | ) | (i) | ||||||||||||||||
(9,004 | ) | (j) | ||||||||||||||||
(6,932 | ) | (n) | ||||||||||||||||
Accumulated other comprehensive income (loss) |
— | (300 | ) | — | (300 | ) | ||||||||||||
Total stockholders’ (deficit) equity |
(100,942 | ) | 1,251,635 | 624,072 | 1,774,765 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
TOTAL |
691,717 | 3,111,259 | (612,448 | ) | 3,190,528 | |||||||||||||
|
|
|
|
|
|
|
|
Dragoneer (Historical) |
CCC (Historical) |
Pro Forma Adjustments |
Pro Forma |
|||||||||||||||
Revenue |
$ | — | $ | 324,578 | $ | — | $ | 324,578 | ||||||||||
Cost of revenue |
— | 90,105 | 98 | (gg) | 90,203 | |||||||||||||
|
|
|||||||||||||||||
Gross profit |
234,473 | (98 | ) | 234,375 | ||||||||||||||
Operating expenses: |
||||||||||||||||||
Research and development |
— | 61,877 | 234 | (gg) | 62,111 | |||||||||||||
Amortization of intangible assets |
— | 36,155 | — | 36,155 | ||||||||||||||
Selling and marketing |
— | 40,968 | 403 | (gg) |
41,371 | |||||||||||||
General and administrative |
— | 66,233 | 1,520 | (gg) |
73,155 | |||||||||||||
5,402 | (hh) |
|||||||||||||||||
Formation and operating costs |
5,402 | — | (5,402 | ) | (hh) |
— | ||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
Total operating expenses |
5,402 | 205,233 | 2,157 | 212,792 | ||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
Operating income (loss) |
(5,402 | ) | 29,240 | (2,255 | ) | 21,583 | ||||||||||||
Other income (expense): |
||||||||||||||||||
Interest income (expense) |
(2,000 | ) | (37,669 | ) | 11,487 | (jj) |
(28,182 | ) | ||||||||||
Gain (loss) on change in fair value of interest rate swaps |
— | 6,366 | — | 6,366 | ||||||||||||||
Interest earned on marketable securities held in Trust Account |
22 | — | — | 22 | ||||||||||||||
Other income, net |
— | 91 | — | 91 | ||||||||||||||
Change in fair value of warrant liabilities |
87,695 | — | — | 87,695 | ||||||||||||||
Changes in fair value of conversion option on working capital loan |
(365 | ) | — | — | (365 | ) | ||||||||||||
Gain on FPA liability |
63,044 | — | — | 63,044 | ||||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
Total other income (expense) |
148,396 | (31,212 | ) | 11,487 | 128,671 | |||||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
Pretax income (loss) |
142,994 | (1,972 | ) | 9,232 | 150,254 | |||||||||||||
Income tax benefit (expense) |
— | 704 | (32,257 | ) | (ee) |
(31,553 | ) | |||||||||||
|
|
|
|
|
|
|
|
|
||||||||||
Net income (loss) |
$ | 142,994 | $ | (1,268 | ) | $ | (23,025 | ) | $ | 118,701 | ||||||||
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average shares outstanding common stock – basic |
1,483,634 | 594,367,578 | ||||||||||||||||
Weighted averages shares outstanding – common stock – diluted |
1,483,634 | 612,553,666 | ||||||||||||||||
Common stock – basic |
$ | (0.85 | ) | $ | 0.20 | |||||||||||||
Common stock – diluted |
$ | (0.85 | ) | $ | 0.19 | |||||||||||||
Weighted-average shares outstanding – Class A Ordinary Shares |
69,000,000 | |||||||||||||||||
Class A ordinary share – basic and diluted |
$ | 0.00 | ||||||||||||||||
Weighted average shares outstanding – Class B non-redeemable ordinary shares |
17,250,000 | |||||||||||||||||
Class B non-redeemable ordinary shares – basic and diluted |
$ | 8.29 |
Dragoneer (Historical) |
CCC (Historical) |
Pro Forma Adjustments |
Pro Forma |
|||||||||||||||
Revenue |
$ | — | $ | 633,063 | $ | — | $ | 633,063 | ||||||||||
Cost of revenue |
— | 208,717 | 9,581 | (bb) | 218,495 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
197 | (cc) | |||||||||||||||||
Gross profit |
— | 424,346 | (9,778 | ) | 414,568 | |||||||||||||
Operating expenses: |
||||||||||||||||||
Research and development |
— | 109,508 | 22,769 | (bb) | 132,744 | |||||||||||||
467 | (cc) | |||||||||||||||||
Amortization and Intangible Assets |
— | 72,310 | — | 72,310 | ||||||||||||||
Selling and marketing |
— | 74,710 | 39,254 | (bb) | 114,769 | |||||||||||||
805 | (cc) | |||||||||||||||||
General and administrative |
— | 90,838 | 16,397 | (aa) | 267,714 | |||||||||||||
148,251 | (bb) | |||||||||||||||||
3,041 | (cc) | |||||||||||||||||
9,187 | (ff) | |||||||||||||||||
Formation and operating costs |
1,043 | — | (1,043 | ) | (ff) | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Total operating expenses |
1,043 | 347,366 | 239,128 | 587,537 | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Operating income (loss) |
(1,043 | ) | 76,980 | (248,906 | ) | (172,969 | ) | |||||||||||
Other income (expense): |
||||||||||||||||||
Interest expense |
— | (77,003 | ) | 22,972 | (ii.1) | (54,031 | ) | |||||||||||
Loss on change in fair value of interest rate swaps |
— | (13,249 | ) | — | (13,249 | ) | ||||||||||||
Loss on early retirement of debt |
— | (8,615 | ) | (6,932 | ) | (ii.2) | (15,547 | ) | ||||||||||
Other income, net |
— | 332 | — | 332 | ||||||||||||||
Change in fair value of warrant liabilities |
(106,715 | ) | — | — | (106,715 | ) | ||||||||||||
Loss on FPA liability |
(69,875 | ) | — | — | (69,875 | ) | ||||||||||||
Compensation expense on private placement warrants |
(6,993 | ) | — | 6,993 | (ff) | — | ||||||||||||
Offering costs allocated to warrant liabilities |
(1,151 | ) | — | 1,151 | (ff) | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Pretax loss |
(185,777 | ) | (21,555 | ) | (224,722 | ) | (432,054 | ) | ||||||||||
Income tax benefit |
— | 4,679 | 86,052 | (ee) | 90,731 | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||||
Net loss |
$ | (185,777 | ) | $ | (16,876 | ) | $ | (138,670 | ) | $ | (341,323 | ) | ||||||
|
|
|
|
|
|
|
|
|||||||||||
Weighted average shares outstanding – Common stock |
1,480,296 | 593,230,820 | ||||||||||||||||
Common stock- basic and diluted |
$ | (11.40 | ) | $ | (0.58 | ) | ||||||||||||
Weighted-average shares outstanding – Class A Ordinary Shares |
69,000,000 | |||||||||||||||||
Class A ordinary shares – basic and diluted |
$ | 0.00 | ||||||||||||||||
Weighted average shares outstanding – Class B non-redeemable ordinary shares |
16,748,571 | |||||||||||||||||
Class B non-redeemable ordinary shares – basic and diluted |
$ | (11.09 | ) |
Shares |
Ownership % |
Voting Right % |
||||||||||
Advent Investor(1) |
372,634,844 | 62.7 | % | 62.7 | % | |||||||
OH Investor(1) |
53,082,833 | 8.9 | % | 8.9 | % | |||||||
TCV Investor(1) |
53,082,832 | 8.9 | % | 8.9 | % | |||||||
Other legacy CCC shareholders(1)(4) |
26,629,869 | 4.5 | % | 4.5 | % | |||||||
Dragoneer public shareholders(2) |
47,990,002 | 8.1 | % | 8.1 | % | |||||||
Sponsor, Dragoneer Funding I LLC and other initial shareholders and certain affiliates of Willett Advisors LLC(1)(3) |
26,125,000 | 4.4 | % | 4.4 | % | |||||||
PIPE Investors |
15,000,000 | 2.5 | % | 2.5 | % | |||||||
|
|
|
|
|
|
|||||||
Total |
594,545,380 | 100.00 | % | 100.00 | % | |||||||
|
|
|
|
|
|
(1) | These ownership percentages do not give effect to the CCC Earnout Shares that may be issued upon the CCC Triggering Event and exclude the Sponsor Earnout Shares that are subject to forfeiture if a Sponsor Triggering Event does not occur. |
(2) | Excludes shares acquired by certain public investors in connection with the PIPE Financing. |
(3) | Includes the shares of New CCC Common Stock resulting from the conversion of Class A ordinary shares initially issued to Dragoneer Funding LLC and certain affiliates of Willett Advisors LLC as part of the forward purchase units that were issued immediately prior to the closing of the Business Combination and pursuant to the terms and conditions of the Forward Purchase Agreements. |
(4) | Excludes shares owned by the Advent Investor, OH Investor and TCV Investor. |
• | The pre-combination equityholders of CCC hold the majority of voting rights in New CCC; |
• | The pre-combination equityholders of CCC have the right to appoint the majority of the directors on the New CCC Board; |
• | Senior management of CCC comprises the senior management of New CCC; and |
• | Operations of CCC comprises the ongoing operations of New CCC. |
• | Dragoneer’s unaudited condensed balance sheet as of June 30, 2021 and the related notes, incorporated by reference, and |
• | CCC’s unaudited condensed consolidated balance sheet as of June 30, 2021 and the related notes, incorporated by reference. |
• | Dragoneer’s condensed statement of operations for the six months ended June 30, 2021, incorporated by reference, and |
• | CCC’s condensed consolidated statement of operations and comprehensive income (loss) for the six months ended June 30, 2021, incorporated by reference. |
• | Dragoneer’s restated statement of operations for the period from July 3, 2020 through December 31, 2020, incorporated by reference, and |
• | CCC’s consolidated statement of operations and comprehensive loss for the year ended December 31, 2020, incorporated by reference. |
Six Months ended June 30, 2021 |
||||
Pro Forma Income per Share |
||||
Numerator: |
||||
Pro forma net income attributable to common stockholders total—basic and diluted |
$ | 118,701 | ||
|
|
|||
Denominator: Basic |
||||
Historical weighted average shares outstanding—basic (as reported) |
1,483,634 | |||
Exchange Ratio |
340.55 | |||
Weighted average number of shares outstanding, as exchanged—basic |
505,252,576 | |||
Pro forma adjustment for shares issued |
89,115,002 | |||
Pro forma weighted average shares outstanding—basic (actual redemptions) |
594,367,578 |
|||
Denominator: Diluted |
||||
Historical weighted average shares outstanding—diluted |
1,537,036 | |||
Exchange ratio |
340.55 | |||
Weighted average number of shares outstanding, as exchanged—diluted |
523,438,664 | |||
Pro forma adjustment for shares issued |
89,115,002 | |||
Pro forma weighted average shares outstanding—diluted (actual redemptions) |
612,553,666 |
|||
Pro forma net income per share: |
||||
Basic |
$ | 0.20 | ||
Diluted |
$ | 0.19 |
Year ended December 31, 2020 |
||||
Pro Forma Loss per Share |
||||
Numerator: |
||||
Pro forma net loss attributable to common stockholders total—basic and diluted |
$ | (341,323 | ) | |
|
|
|||
Denominator: |
||||
Historical weighted average shares outstanding—basic and diluted (as reported) |
1,480,296 | |||
Exchange Ratio |
340.55 | |||
Weighted average number of shares outstanding, as exchanged—basic and diluted |
504,115,818 | |||
Pro forma adjustment for shares issued |
89,115,002 | |||
Pro forma weighted average shares outstanding—basic and diluted |
593,230,820 | |||
Pro forma net loss per share: |
||||
Basic and diluted |
$ | (0.58 | ) |
• | the provisions regarding the size of the New CCC Board and the election of directors pursuant to the Amended and Restated Registration and Shareholder Rights Agreement; |
• | the provisions regarding stockholder actions without a meeting; |
• | the provisions regarding calling special meetings of stockholders; |
• | the provisions regarding removal of directors; |
• | the provisions regarding the limited liability of directors of New CCC; |
• | the provisions regarding competition and corporate opportunities; and |
• | the provisions regarding the election not to be governed by Section 203 of the DGCL. |
1. | the board of directors approves the acquisition of stock or the merger transaction before the time that the person becomes an interested stockholder; |
2. | the interested stockholder owns at least 85% of the outstanding voting stock of the corporation at the time the merger transaction commences (excluding voting stock owned by directors who are also officers and certain employee stock plans); or |
3. | the merger transaction is approved by the board of directors and at a meeting of stockholders, not by written consent, by the affirmative vote of 2/3 of the outstanding voting stock which is not owned by the interested stockholder. A Delaware corporation may elect in its certificate of incorporation or bylaws not to be governed by this particular Delaware law. |
• | prior to such time, our board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder; |
• | upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of our voting stock outstanding at the time the transaction commenced, excluding certain shares; or |
• | at or subsequent to that time, the business combination is approved by our board of directors and by the affirmative vote of holders of at least 66-2/3% of the outstanding voting stock that is not owned by the interested stockholder. |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Common Stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) on the trading day prior to the date on which we send the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided |
• | if, and only if, the closing price of our Common Stock equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—Warrants—Public Shareholders’ Warrants—Anti-Dilution Adjustments”) on the trading day prior to the date on which we send the notice of redemption to the warrant holders. |
Redemption Date (period to expiration of warrants) |
Fair Market Value of Common Stock |
|||||||||||||||||||||||||||||||||||
£ 10.00 |
11.00 |
12.00 |
13.00 |
14.00 |
15.00 |
16.00 |
17.00 |
³ 18.00 |
||||||||||||||||||||||||||||
60 months |
0.261 | 0.281 | 0.297 | 0.311 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
57 months |
0.257 | 0.277 | 0.294 | 0.310 | 0.324 | 0.337 | 0.348 | 0.358 | 0.361 | |||||||||||||||||||||||||||
54 months |
0.252 | 0.272 | 0.291 | 0.307 | 0.322 | 0.335 | 0.347 | 0.357 | 0.361 | |||||||||||||||||||||||||||
51 months |
0.246 | 0.268 | 0.287 | 0.304 | 0.320 | 0.333 | 0.346 | 0.357 | 0.361 | |||||||||||||||||||||||||||
48 months |
0.241 | 0.263 | 0.283 | 0.301 | 0.317 | 0.332 | 0.344 | 0.356 | 0.361 | |||||||||||||||||||||||||||
45 months |
0.235 | 0.258 | 0.279 | 0.298 | 0.315 | 0.330 | 0.343 | 0.356 | 0.361 | |||||||||||||||||||||||||||
42 months |
0.228 | 0.252 | 0.274 | 0.294 | 0.312 | 0.328 | 0.342 | 0.355 | 0.361 | |||||||||||||||||||||||||||
39 months |
0.221 | 0.246 | 0.269 | 0.290 | 0.309 | 0.325 | 0.340 | 0.354 | 0.361 | |||||||||||||||||||||||||||
36 months |
0.213 | 0.239 | 0.263 | 0.285 | 0.305 | 0.323 | 0.339 | 0.353 | 0.361 | |||||||||||||||||||||||||||
33 months |
0.205 | 0.232 | 0.257 | 0.280 | 0.301 | 0.320 | 0.337 | 0.352 | 0.361 | |||||||||||||||||||||||||||
30 months |
0.196 | 0.224 | 0.250 | 0.274 | 0.297 | 0.316 | 0.335 | 0.351 | 0.361 | |||||||||||||||||||||||||||
27 months |
0.185 | 0.214 | 0.242 | 0.268 | 0.291 | 0.313 | 0.332 | 0.350 | 0.361 | |||||||||||||||||||||||||||
24 months |
0.173 | 0.204 | 0.233 | 0.260 | 0.285 | 0.308 | 0.329 | 0.348 | 0.361 | |||||||||||||||||||||||||||
21 months |
0.161 | 0.193 | 0.223 | 0.252 | 0.279 | 0.304 | 0.326 | 0.347 | 0.361 | |||||||||||||||||||||||||||
18 months |
0.146 | 0.179 | 0.211 | 0.242 | 0.271 | 0.298 | 0.322 | 0.345 | 0.361 | |||||||||||||||||||||||||||
15 months |
0.130 | 0.164 | 0.197 | 0.230 | 0.262 | 0.291 | 0.317 | 0.342 | 0.361 | |||||||||||||||||||||||||||
12 months |
0.111 | 0.146 | 0.181 | 0.216 | 0.250 | 0.282 | 0.312 | 0.339 | 0.361 | |||||||||||||||||||||||||||
9 months |
0.090 | 0.125 | 0.162 | 0.199 | 0.237 | 0.272 | 0.305 | 0.336 | 0.361 | |||||||||||||||||||||||||||
6 months |
0.065 | 0.099 | 0.137 | 0.178 | 0.219 | 0.259 | 0.296 | 0.331 | 0.361 | |||||||||||||||||||||||||||
3 months |
0.034 | 0.065 | 0.104 | 0.150 | 0.197 | 0.243 | 0.286 | 0.326 | 0.361 | |||||||||||||||||||||||||||
0 months |
— | — | 0.042 | 0.115 | 0.179 | 0.233 | 0.281 | 0.323 | 0.361 |
• | each person known by New CCC to be the beneficial owner of more than 5% of New CCC’s outstanding Common Stock immediately following the consummation of the Transactions; |
• | each of New CCC’s named executive officers and directors; and |
• | all of New CCC’s executive officers and directors as a group. |
Name and Address of Beneficial Owners(1) |
Number of Shares |
% |
||||||
Githesh Ramamurthy |
33,514,136 | 5.6 | % | |||||
Brian Herb |
1,004,623 | * | ||||||
Barrett Callaghan |
2,758,459 | * | ||||||
Steve G. Puccinelli |
— | — | ||||||
William Ingram |
110,678 | * | ||||||
David Yuan |
— | — | ||||||
Eileen Schloss |
85,187 | * | ||||||
Teri Williams |
— | — | ||||||
Christopher Egan |
— | — | ||||||
Eric Wei |
— | — | ||||||
Lauren Young |
— | — |
Name and Address of Beneficial Owners |
Number of Shares |
% |
||||||
All directors and executive officers (15 persons) |
37,473,033 | 6.2 | % | |||||
Five Percent Holders: |
||||||||
Affiliates of Advent Investors(2) |
373,134,844 | 61.8 | % | |||||
OH Cypress Aggregator, L.P.(3) |
53,082,833 | 8.8 | % | |||||
TCV Investor(4) |
53,082,832 | 8.8 | % | |||||
Dragoneer Funding I LLC(5) |
52,460,716 | 8.7 | % |
* | Less than 1% |
(1) | Unless otherwise noted, the business address of each of the directors and officers is 222 Merchandise Mart Plaza, Suite 900, Chicago, Illinois 60654. The table excludes the contingent right of Mr. Ramamurthy, Mr. Herb and Mr. Callaghan to receive an aggregate of up to 581,070, 38,632 and 81,748 CCC Earnout Shares, respectively. |
(2) | Cypress Investor Holdings, L.P. (“Cypress Investor”), Advent International GPE VIII-C Limited Partnership (“Advent International VIII-C”) GPE VIII CCC Co-Investment (Delaware) Limited Partnership (“GPE VIII CCC Co-Investment”) and Sunley House Capital Master Fund Limited Partnership (“Sunley House Master Fund”) are the record holders of 273,339,593 shares, 8,645,086 shares 90,650,165 shares and 500,000 shares of the Common Stock, respectively. Cypress Investor. is beneficially owned by Advent International GPE VIII Limited Partnership (“Advent International VIII”), Advent International GPE VIII-A Limited Partnership (“Advent International VIII-A”), Advent International GPE VIII-B-1 VIII-B-1”), VIII-B-2 VIII-B-2”), VIII-B-3 VIII-B-3”), VIII-B Limited Partnership (“Advent International VIII-B”), Advent International GPE VIII-D Limited Partnership (“Advent International VIII-D”), Advent International GPE VIII-E Limited Partnership (“Advent International VIII-E”), Advent International GPE VIII-F Limited Partnership (“Advent International VIII-F”), Advent International GPE VIII-G Limited Partnership (“Advent International VIII-G”), Advent International GPE VIII-H Limited Partnership (“Advent International VIII-H”), Advent International GPE VIII-I Limited Partnership (“Advent International VIII-I”), Advent International GPE VIII-J Limited Partnership (“Advent International VIII-J” and together with Advent International VIII, Advent International VIII-B-1, Advent International VIII-B-2, Advent International VIII-B-3, Advent International VIII-B, Advent International VIII-D, Advent International VIII-F, Advent International VIII-H and Advent International VIII-I, the “Advent Luxembourg Funds”), Advent International GPE VIII-K Limited Partnership (“Advent International VIII-K”), Advent International GPE VIII-L Limited Partnership (“Advent International VIII-L” and together with Advent International VIII-A, Advent International VIII-E, Advent International VIII-G and Advent International VIII-K, the “Advent Cayman Funds”), Advent Partners GPE VIII Limited Partnership (“Advent Partners VIII”), Advent Partners GPE VIII-A Limited Partnership (“Advent Partners VIII-A”), Advent Partners GPE VIII Cayman Limited Partnership (“Advent Partners VIII Cayman”), Advent Partners GPE VIII-A Cayman Limited Partnership (“Advent Partners VIII-A Cayman”) and Advent Partners GPE VIII-B Cayman Limited Partnership (“Advent Partners VIII-B Cayman” and together with Advent Partners VIII, Advent Partners VIII-A, Advent Partners VIII Cayman and Advent Partners VIII-A Cayman, the “Advent Partners Funds”). The Advent Luxembourg Funds, the Advent Cayman Funds and the Advent Partners Funds have ownership interests in Cypress Investor, but none of the Advent Luxembourg Funds, the Advent Cayman Funds or the Advent Partners Funds has voting or dispositive power over any shares. GPE VIII GP S.à r.l. is the general partner the of Advent Luxembourg Funds and Advent International VIII-C. GPE VIII GP Limited Partnership is the general partner of the Advent Cayman Funds, and GPE VIII CCC Co-Investment. AP GPE VIII GP Limited Partnership is the general partner of the Advent Partners Funds. Advent International GPE VIII, LLC is the manager of GPE VIII GP S.à r.l. and the general partner of each of GPE VIII GP Limited Partnership and AP GPE VIII GP Limited Partnership. Sunley House Capital GP LP (“Sunley House GP LP”), as general partner of Sunley House Master Fund, Sunley House Capital GP LLC (“Sunley House GP LLC”), as general partner of Sunley House GP LP, and Sunley House Capital Management LLC (“Sunley House Manager”), as investment manager to Sunley House Master Fund, may be deemed to beneficially own the shares held directly by Sunley House Master Fund. Advent International Corporation is the manager of Advent International GPE VIII, LLC and is the sole member of both Sunley House GP LLC and Sunley House Manager. Investors in the Sunley House Master Fund invest in one or more of the following feeder funds: Sunley House Capital Fund LP, Sunley House Capital Limited Partnership, Sunley House Capital Fund Ltd. and Sunley House Capital Ltd. (collectively, the “Sunley House Feeder Funds”), which are the limited partners of the Sunley House Master Fund. The Sunley House Feeder Funds have ownership interests in the Sunley House Master Fund, but none of the Sunley House Feeder Funds owns shares directly and none has voting or dispositive power over the shares held directly by the Sunley House Master Fund. The foregoing excludes the contingent right of Cypress Investor, Advent International VIII-C |
and GPE VIII CCC Co-Investment to receive an aggregate of up to 9,919,012 CCC Earnout Shares. Voting and investment decisions by Advent International Corporation are made by a number of individuals currently comprised of John L. Maldonado, David M. McKenna and David M. Mussafer. The address of each of the entities and individuals named in this footnote is c/o Advent International Corporation, Prudential Tower, 800 Boylston St., Suite 3300, Boston, MA 02199. |
(3) | OH Cypress Aggregator, L.P. is beneficially owned by Oak Hill Capital Partners IV (Onshore), L.P., Oak Hill Capital Partners IV (Onshore Tax Exempt), L.P., Oak Hill Capital Partners IV (Offshore), L.P., Oak Hill Capital Partners IV (Offshore 892), L.P., Oak Hill Capital Partners IV (Management), L.P. (together, including OH Cypress Aggregator, the “Oak Hill Fund IV Entities”) and certain of their co-investors. The general partner of each of the Oak Hill Fund IV Entities is OHCP GenPar IV, L.P. (the “Oak Hill GP”). The general partner of Oak Hill GP is OHCP MGP IV, Ltd. (the “Oak Hill UGP”). The foregoing excludes the contingent right of OH Cypress Aggregator, L.P. to receive an aggregate of up to 1,412,990 CCC Earnout Shares. The three managing partners of Oak Hill, Tyler Wolfram, Brian Cherry and Steven Puccinelli, serve as the directors of the Oak Hill UGP and may be deemed to exercise voting and investment control over the shares held by the Oak Hill Fund IV Entities. The address for these entities is 65 East 55th Street, 32nd Floor, New York, NY 10022. |
(4) | The general partner of TCV Member Fund, L.P. (the “Member Fund”) is Technology Crossover Management IX, Ltd. (“Management IX”), and the general partner of each of TCV IX, L.P., TCV IX (A), L.P., and TCV IX (B), L.P. (together with the Member Fund, the “TCV IX Funds”) is Technology Crossover Management IX, L.P. (“TCM IX”). The general partner of TCM IX is Management IX. Management IX and TCM IX may be deemed to beneficially own the securities held by the TCV IX Funds directly or indirectly controlled by them, but each disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. The foregoing excludes the contingent right of the TCV Investor to receive an aggregate of up to 1,412,988 CCC Earnout Shares. Jay C. Hoag, Jon Q. Reynolds Jr., Timothy P. McAdam and Christopher P. Marshall are the Class A Directors of Management IX, and each disclaims beneficial ownership of the securities held by the TCV IX Funds except to the extent of his pecuniary interest therein. The address of the entities named in this footnote is 250 Middlefield Road, Menlo Park, CA 94025. |
(5) | Consists of (i) 18,800,000 warrants to purchase Common Stock, (ii) 16,660,716 shares of Common Stock acquired from a transfer by the Sponsor and (iii) 15,000,000 shares of Common stock acquired from transfers from Dragoneer Global Fund II, L.P. and Dragoneer Opportunities Fund V, L.P. Shares of Common Stock are inclusive of the share of Common Stock issuable upon exercise of Dragoneer Funding I LLC’s warrants. The ultimate managing member of Dragoneer Funding I, LLC is controlled by Marc Stad and he may be deemed to share voting and dispositive power with respect to the securities held by such entity. The business address of Dragoneer Funding I LLC and Mr. Stad is c/o Dragoneer Investment Group, LLC, One Letterman Drive, Building D, Suite M500, San Francisco, California. |
Securities Beneficially Owned Prior to This Offering |
Securities to be Sold in This Offering |
Securities Beneficially Owned After This Offering |
||||||||||||||||||||||||||||||
Shares of Common Stock (1) |
Warrants (2) |
Shares of Common Stock (1) |
Warrants (2) |
Shares of Common Stock (1) |
% |
Warrants (2) |
% |
|||||||||||||||||||||||||
Affiliates of Advent Investors (3) |
373,134,844 | — | 373,134,844 | — | — | — | — | — | ||||||||||||||||||||||||
OH Cypress Aggregator, L.P.(4) |
53,082,833 | — | 53,082,833 | — | — | — | — | — | ||||||||||||||||||||||||
TCV Investors(5) |
53,082,832 | — | 53,082,832 | — | — | — | — | — | ||||||||||||||||||||||||
Dragoneer Funding I LLC(6) |
50,460,716 | 18,800,000 | 50,460,716 | 18,800,000 | — | — | — | — | ||||||||||||||||||||||||
Affiliates of Willett Advisors(7) |
3,214,284 | 500,000 | 3,214,284 | 500,000 | — | — | — | — |
Securities Beneficially Owned Prior to This Offering |
Securities to be Sold in This Offering |
Securities Beneficially Owned After This Offering |
||||||||||||||||||||||||||||||
Shares of Common Stock (1) |
Warrants (2) |
Shares of Common Stock (1) |
Warrants (2) |
Shares of Common Stock (1) |
% |
Warrants (2) |
% |
|||||||||||||||||||||||||
Dragoneer Growth Opportunities Holdings(8) |
2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | — | — | — | — | ||||||||||||||||||||||||
Githesh Ramamurthy |
16,214,844 | — | 16,214,844 | — | — | — | — | — | ||||||||||||||||||||||||
Barrett Callaghan |
1,021,652 | — | 1,021,652 | — | — | — | — | — | ||||||||||||||||||||||||
Marc Fredman |
374,605 | — | 374,605 | — | — | — | — | — | ||||||||||||||||||||||||
Brian Herb |
340,550 | — | 340,550 | — | — | — | — | — | ||||||||||||||||||||||||
Peter Morowski |
851,376 | — | 851,376 | — | — | — | — | — | ||||||||||||||||||||||||
Mary Jo Prigge |
853,085 | — | 853,085 | — | — | — | — | — | ||||||||||||||||||||||||
Altimeter Partners Fund, L.P.(9) |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Funds associated with Capital Research and Management Company(10) |
4,000,000 | — | 4,000,000 | — | — | — | — | — | ||||||||||||||||||||||||
Coatue Fintech Fund I LP(11) |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
D1 Capital Partners Master, L.P.(12) |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Affiliates of Fidelity(13) |
2,500,000 | — | 2,500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Franklin Strategic Series Franklin Growth Opportunities Fund(14) |
416,700 | — | 416,700 | — | — | — | — | — | ||||||||||||||||||||||||
Franklin Templeton Investment Funds Franklin U.S. Opportunities Fund(15) |
583,300 | — | 583,300 | — | — | — | — | — | ||||||||||||||||||||||||
Affiliates of Investment Group of Santa Barbara(16) |
1,000,000 | — | 1,000,000 | — | — | — | — | — | ||||||||||||||||||||||||
Affiliates of Janus Henderson(17) |
1,000,000 | — | 1,000,000 | — | — | — | — | — | ||||||||||||||||||||||||
Affiliates of Maverick Capital(18) |
500,000 | — | 500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Affiliates of MFS Investment Management(19) |
3,389,847 | — | 500,000 | — | 2,889,847 | * | — | — | ||||||||||||||||||||||||
Affiliates of T.Rowe Price(20) |
2,500,000 | — | 2,500,000 | — | — | — | — | — | ||||||||||||||||||||||||
Additional selling securityholders(21) |
375,000 | — | 375,000 | — | — | — | — | — | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
TOTAL |
572,396,468 | 21,300,000 | 569,506,621 | 21,300,000 | 2,889,847 | * | — | — | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
* | Represents less than 1%. |
(1) | Represents shares of Common Stock, including the shares of Common Stock that may be issued upon the exercise of Warrants. |
(2) | Represents the Public Warrants, the Private Placement Warrants and the Forward Purchase Warrants. |
(3) | Cypress Investor Holdings, L.P. (“Cypress Investor”), Advent International GPE VIII-C Limited Partnership (“Advent International VIII-C”), GPE VIII CCC Co-Investment (Delaware) Limited Partnership (“GPE VIII CCC Co-Investment”) and Sunley House Capital Master Fund Limited Partnership (“Sunley House Master Fund”) are the record holders of 273,339,593 shares, 8,645,086 shares, 90,650,165 shares and 500,000 shares of the Common Stock, respectively. Cypress Investor is beneficially owned by Advent International GPE VIII Limited Partnership (“Advent International VIII”), Advent International GPE VIII-A Limited Partnership (“Advent International VIII-A”), Advent International GPE VIII-B-1 Limited Partnership (“Advent International VIII-B-1”), Advent International GPE VIII-B-2 Limited Partnership (“Advent International VIII-B-2”), Advent International GPE VIII-B-3 Limited Partnership (“Advent International VIII-B-3”), Advent International GPE VIII-B Limited Partnership (“Advent International VIII-B”), Advent International GPE VIII-D Limited Partnership (“Advent International VIII-D”), Advent International GPE VIII-E Limited Partnership (“Advent International VIII-E”), Advent International GPE VIII-F Limited Partnership (“Advent International VIII-F”), Advent International GPE VIII-G Limited Partnership (“Advent International VIII-G”), Advent International GPE VIII-H Limited Partnership (“Advent International VIII-H”), Advent International GPE VIII-I Limited Partnership (“Advent International VIII-I”), Advent International GPE VIII-J Limited Partnership (“Advent International VIII-J” and together with Advent International VIII, Advent International VIII-B-1, Advent International VIII-B-2, Advent International VIII-B-3, Advent International VIII-B, Advent International VIII-D, Advent International VIII-F, Advent International VIII-H and Advent International VIII-I, the “Advent Luxembourg Funds”), Advent International GPE VIII-K Limited Partnership (“Advent International VIII-K”), Advent International GPE VIII-L Limited Partnership (“Advent International VIII-L” and together with Advent International VIII-A, Advent International VIII-E, Advent International VIII-G and Advent International |
VIII-K, the “Advent Cayman Funds”), Advent Partners GPE VIII Limited Partnership (“Advent Partners VIII”), Advent Partners GPE VIII-A Limited Partnership (“Advent Partners VIII-A”), Advent Partners GPE VIII Cayman Limited Partnership (“Advent Partners VIII Cayman”), Advent Partners GPE VIII-A Cayman Limited Partnership (“Advent Partners VIII-A Cayman”) and Advent Partners GPE VIII-B Cayman Limited Partnership (“Advent Partners VIII-B Cayman” and together with Advent Partners VIII, Advent Partners VIII-A, Advent Partners VIII Cayman and Advent Partners VIII-A Cayman, the “Advent Partners Funds”). The Advent Luxembourg Funds, the Advent Cayman Funds and the Advent Partners Funds have ownership interests in Cypress Investor, but none of the Advent Luxembourg Funds, the Advent Cayman Funds or the Advent Partners Funds has voting or dispositive power over any shares. GPE VIII GP S.à r.l. is the general partner of the Advent Luxembourg Funds and Advent International VIII-C. GPE VIII GP Limited Partnership is the general partner of the Advent Cayman Funds and GPE VIII CCC Co-Investment. AP GPE VIII GP Limited Partnership is the general partner of the Advent Partners Funds. Advent International GPE VIII, LLC is the manager of GPE VIII GP S.à r.l. and the general partner of each of GPE VIII GP Limited Partnership and AP GPE VIII GP Limited Partnership. Sunley House Capital GP LP (“Sunley House GP LP”), as general partner of Sunley House Master Fund, Sunley House Capital GP LLC (“Sunley House GP LLC”), as general partner of Sunley House GP LP, and Sunley House Capital Management LLC (“Sunley House Manager”), as investment manager to Sunley House Master Fund, may be deemed to beneficially own the shares held directly by Sunley House Master Fund. Advent International Corporation is the manager of Advent International GPE VIII, LLC and is the sole member of both Sunley House GP LLC and Sunley House Manager. Investors in the Sunley House Master Fund invest in one or more of the following feeder funds: Sunley House Capital Fund LP, Sunley House Capital Limited Partnership, Sunley House Capital Fund Ltd. and Sunley House Capital Ltd. (collectively, the “Sunley House Feeder Funds”), which are the limited partners of the Sunley House Master Fund. The Sunley House Feeder Funds have ownership interests in the Sunley House Master Fund, but none of the Sunley House Feeder Funds owns shares directly and none has voting or dispositive power over the shares held directly by the Sunley House Master Fund. The foregoing excludes the contingent right of Cypress Investor, Advent International VIII-C and GPE VIII CCC Co-Investment to receive an aggregate of up to 9,919,012 CCC Earnout Shares. Voting and investment decisions by Advent International Corporation are made by a number of individuals currently comprised of John L. Maldonado, David M. McKenna and David M. Mussafer. The address of each of the entities and individuals named in this footnote is c/o Advent International Corporation, Prudential Tower, 800 Boylston St., Suite 3300, Boston, MA 02199. |
(4) | OH Cypress Aggregator, L.P. is beneficially owned by Oak Hill Capital Partners IV (Onshore), L.P., Oak Hill Capital Partners IV (Onshore Tax Exempt), L.P., Oak Hill Capital Partners IV (Offshore), L.P., Oak Hill Capital Partners IV (Offshore 892), L.P., Oak Hill Capital Partners IV (Management), L.P. (together, including OH Cypress Aggregator, the “Oak Hill Fund IV Entities”) and certain of their co-investors. The general partner of each of the Oak Hill Fund IV Entities is OHCP GenPar IV, L.P. (the “Oak Hill GP”). The general partner of Oak Hill GP is OHCP MGP IV, Ltd. (the “Oak Hill UGP”). The foregoing excludes the contingent right of OH Cypress Aggregator, L.P. to receive an aggregate of up to 1,412,990 CCC Earnout Shares. The three managing partners of Oak Hill, Tyler Wolfram, Brian Cherry and Steven Puccinelli, serve as the directors of the Oak Hill UGP and may be deemed to exercise voting and investment control over the shares held by the Oak Hill Fund IV Entities. The address for these entities is 65 East 55th Street, 32nd Floor, New York, NY 10022. |
(5) | The general partner of TCV Member Fund, L.P. (the “Member Fund”) is Technology Crossover Management IX, Ltd. (“Management IX”), and the general partner of each of TCV IX, L.P., TCV IX (A), L.P., and TCV IX (B), L.P. (together with the Member Fund, the “TCV IX Funds”) is Technology Crossover Management IX, L.P. (“TCM IX”). The general partner of TCM IX is Management IX. Management IX and TCM IX may be deemed to beneficially own the securities held by the TCV IX Funds directly or indirectly controlled by them, but each disclaims beneficial ownership of such shares except to the extent of its pecuniary interest therein. The foregoing excludes the contingent right of the TCV Investor to receive an aggregate of up to 1,412,988 CCC Earnout Shares. Jay C. Hoag, Jon Q. Reynolds Jr., Timothy P. McAdam and Christopher P. Marshall are the Class A Directors of Management IX, and each disclaims |
beneficial ownership of the securities held by the TCV IX Funds except to the extent of his pecuniary interest therein. The address of the entities named in this footnote is 250 Middlefield Road, Menlo Park, CA 94025. |
(6) | Consists of (i) 18,800,000 warrants to purchase Common Stock, (ii) 16,660,716 shares of Common Stock acquired from a transfer by the Sponsor and (iii) 15,000,000 shares of Common stock acquired from transfers from Dragoneer Global Fund II, L.P. and Dragoneer Opportunities Fund V, L.P. Shares of Common Stock are inclusive of the share of Common Stock issuable upon exercise of Dragoneer Funding I LLC’s warrants. The ultimate managing member of Dragoneer Funding I, LLC is controlled by Marc Stad and he may be deemed to share voting and dispositive power with respect to the securities held by such entity. The business address of Dragoneer Funding I LLC and Mr. Stad is c/o Dragoneer Investment Group, LLC, One Letterman Drive, Building D, Suite M500, San Francisco, California. |
(7) | Represents warrants to purchase Common Stock and Common Stock underlying such warrants acquired pursuant to the Forward Purchase Agreements, including (a) 40,500 warrants to purchase shares of Common Stock, and 40,500 shares of Common Stock underlying such warrants held of record by 63019 Holdings, LLC, (b) 45,000 warrants to purchase shares of Common Stock, and 45,000 shares of Common Stock underlying such warrants held of record by Willett Private Investors I LP, (c) 364,500 warrants to purchase shares of Common Stock, and 364,500 shares of Common Stock underlying such warrants held of record by Willett Private Investors (Tax Exempt) I LP and (d) 50,000 warrants to purchase shares of Common Stock, and 50,000 shares of Common Stock underlying such warrants held of record by Silas Holdings I LLC. Also represents the Class B ordinary shares transferred from the Sponsor to each of the affiliates of Willett Advisors that subsequently converted into Common Stock. The business address of each of the affiliates of Willett Advisors other than Silas Holdings I LLC is c/o Willett Advisors LLC, 650 Madison Avenue, 17th Floor, New York, NY 10022. The business address of Silas Holdings I LLC is c/o Rattner Family Office, 650 Madison Avenue, 17th Floor, New York, NY 10022. |
(8) | Represents the working capital warrants that were issued upon conversion of the principal amount of a working capital loan provided by Sponsor to Dragoneer, which conversion occurred upon the consummation of the Business Combination. The ultimate managing member of Sponsor is controlled by Marc Stad and he may be deemed to share voting and dispositive power with respect to the securities held by such entity. The business address of Sponsor and Mr. Stad is c/o Dragoneer Investment Group, LLC, One Letterman Drive, Building D, Suite M500, San Francisco, California. |
(9) | Represents shares of Common Stock acquired in the PIPE Financing. The shares of Common Stock are directly owned by Altimeter Partners Fund, L.P. (the “Fund”). Brad Gerstner is the sole managing principal of the Altimeter Capital Management General Partner LLC (the “General Partner”), Altimeter Capital Management, LP (the “Investment Manager”) and Altimeter General Partner, LLC (the “Fund General Partner”). The General Partner is the sole general partner of the Investment Manager, which is the investment manager of the Fund. The Fund General Partner is the sole general partner of the Fund. The business address of Altimeter Partners Fund, L.P. is One International Place, Suite 4610, Boston, MA 02110. |
(10) | Consists of shares of Common Stock acquired in the PIPE Financing. Consists of 2,467,640 shares of Common Stock held by The New Economy Fund. Timothy D. Armour, Mathews Cherian, Tomoko Fortune, Caroline Jones, Harold H. La, Reed Lowenstein and Richmond Wolf, as portfolio managers, have voting and investment power over the securities held by The New Economy Fund. Consists of 1,480,590 shares of Common Stock held by The Growth Fund of America. Christopher D. Buchbinder, Mark L. Casey, Barry S. Crosthwaite, J. Blair Frank, Joanna F. Jonsson, Carl M. Kawaja, Donald D. O’Neal, Anne-Marie Peterson, Alex Popa, Andraz Razen, Martin Romo, Lawrence R. Solomon and Alan J. Wilson, as portfolio managers, have voting and investment power over the securities held by The Growth Fund of America. Consists of 32,160 shares of Common Stock held by Capital Group New Economy Fund (LUX). Timothy D. Armour, Mathews Cherian, Tomoko Fortune, Caroline Jones, Harold H. La, Reed Lowenstein and Richmond Wolf, as portfolio managers, have voting and investment power over the securities held by Capital Group New Economy Fund (LUX). Consists of 10,520 shares of Common Stock held by Capital Group Growth Fund of America Trust (US). Christopher D. Buchbinder, Mark L. Casey, Barry S. Crosthwaite, J. Blair Frank, Joanna F. Jonsson, Carl M. Kawaja, Donald D. O’Neal, Anne-Marie Peterson, Alex Popa, Andraz Razen, Martin Romo, Lawrence R. Solomon and Alan J. Wilson, as portfolio managers, have voting and investment power over the securities held by Capital Group Growth Fund of America Trust (US). Consists of 9,090 shares of |
Common Stock held by Capital Group New Economy Trust (US). Timothy D. Armour, Mathews Cherian, Tomoko Fortune, Caroline Jones, Harold H. La, Reed Lowenstein and Richmond Wolf, as portfolio managers, have voting and investment power over the securities held by Capital Group New Economy Trust (US). Capital Research and Management Company is the investment adviser for each of the funds associated with Capital Research and Management Company. The business address of each of the funds associated with Capital Research and Management Company is 333 S. Hope Street, 55th Floor, Los Angeles, CA 90071. |
(11) | Represents shares of Common Stock acquired by Coatue FinTech Fund I LP in the PIPE Financing. Coatue FinTech Fund I LP is managed by Coatue Management, L.L.C. The sole owner of Coatue Management, L.L.C. is Coatue Management Partners LP, for which Coatue Management Partners GP LLC serves as general partner. Mr. Philippe Laffont serves as managing member of Coatue Management Partners GP LLC. Mr. Laffont and Coatue Management, L.L.C. disclaim beneficial ownership of the shares held by Coatue FinTech Fund I LP except to the extent of their pecuniary interest therein. The business address for Mr. Laffont, Coatue Management, L.L.C. and Coatue FinTech Fund I LP is 9 West 57th Street, 25th Floor, New York, NY 10019. |
(12) | Represents shares of Common Stock acquired in the PIPE Financing. The business address of D1 Capital Partners Master, L.P. is 9 West 57th Street, 36th Floor, New York, NY 10019. |
(13) | Represents shares of Common Stock acquired in the PIPE Financing. Represents (a) 428,742 shares of Common Stock held of record by Fidelity Securities Fund: Fidelity Blue Chip Growth Fund, (b) 14,752 shares of Common Stock held of record by Fidelity Blue Chip Growth Commingled Pool, by Fidelity Management Trust Company, as trustee, (c) 892 shares of Common Stock held of record by Fidelity Securities Fund: Fidelity Flex Large Cap Growth Fund, (d) 47,076 shares of Common Stock held of record by Fidelity Securities Fund: Fidelity Blue Chip Growth K6 Fund, (e) 1,161 shares of Common Stock held of record by Fidelity Blue Chip Growth Institutional Trust, by its manager Fidelity Investments Canada ULC, (f) 49,981 shares of Common Stock held of record by Fidelity Securities Fund: Fidelity Series Blue Chip Growth Fund, (g) 34,086 shares of Common Stock held of record by FIAM Target Date Blue Chip Growth Commingled Pool, by Fidelity Institutional Asset Management Trust Company as Trustee, (h) 26,636 shares of Common Stock held of record by Variable Insurance Products Fund III: VIP Growth Opportunities Portfolio, (i) 180,037 shares of Common Stock held of record by Fidelity Advisor Series I: Fidelity Advisor Growth Opportunities Fund, (j) 6,302 shares of Common Stock held of record by Fidelity Advisor Series I: Fidelity Advisor Series Growth Opportunities Fund, (k) 2,248 shares of Common Stock held of record by Fidelity U.S. Growth Opportunities Investment Trust, by its manager Fidelity Investments Canada ULC, (k) 22,661 shares of Common Stock held of record by Fidelity NorthStar Fund - Sub D, by its manager Fidelity Investments Canada ULC, (l) 36,613 shares of Common Stock held of record by Variable Insurance Products Fund III: VIP Balanced Portfolio - Information Technology Sub, (m) 34,443 shares of Common Stock held of record by Fidelity Advisor Series I: Fidelity Advisor Balanced Fund - Information Technology Sub, (n) 3,671 shares of Common Stock held of record by Fidelity Puritan Trust: Fidelity Balanced K6 Fund - Information Technology Sub-portfolio, (o) 253,848 shares of Common Stock held of record by Fidelity Puritan Trust: Fidelity Balanced Fund - Information Technology Sub, (p) 102,045 shares of Common Stock held of record by Fidelity Select Portfolios: Select Technology Portfolio, (q) 134,385 shares of Common Stock held of record by Strategic Advisers Fidelity U.S. Total Stock Fund - FIAM Sector Managed - Technology Sub, (r) 35,655 shares of Common Stock held of record by Strategic Advisers Large Cap Fund - FIAM Sector Managed Technology Sub, by FIAM LLC as Investment Manager , (s) 79,152 shares of Common Stock held of record by Fidelity Mt. Vernon Street Trust: Fidelity Series Growth Company Fund, (t) 411,529 shares of Common Stock held of record by Fidelity Mt. Vernon Street Trust: Fidelity Growth Company Fund , (u) 424,839 shares of Common Stock held of record by Fidelity Growth Company Commingled Pool, by Fidelity Management Trust Company, as Trustee, (v) 81,735 shares of Common Stock held of record by Fidelity Mt. Vernon Street Trust : Fidelity Growth Company K6 Fund, (w) 27,668 shares of Common Stock held of record by Fidelity Trend Fund: Fidelity Trend Fund, (x) 48,511 shares of Common Stock held of record by Fidelity Securities Fund: Fidelity Small Cap Growth Fund, (y) 10,832 shares of Common Stock held of record by Fidelity Securities Fund: Fidelity Small Cap Growth K6 Fund and (z) 500 shares of Common Stock held of record by Fidelity Capital Trust: Fidelity Flex Small Cap Fund - Small Cap Growth Subportfolio. The business address of each of the affiliates of Fidelity is 245 Summer Street, Boston, MA 02110. |
(14) | Represents shares of Common Stock acquired in the PIPE Financing. The business address of Franklin Strategic Series Franklin Growth Opportunities Fund is One Franklin Parkway, San Mateo, CA 94403. |
(15) | Represents shares of Common Stock acquired in the PIPE Financing. The business address of Franklin Templeton Investment Funds Franklin U.S. Opportunities Fund is 8a rue Albert Borschette, L-1246 Luxembourg. |
(16) | Represents shares of Common Stock acquired in the PIPE Financing. Represents (a) 200,000 shares of Common Stock held of record by IGSB Bulldog III, LLC and (b) 800,000 shares of Common Stock held of record by FARMCO, a Nominee of Farmers and Merchants Trust Company of Long Beach. The business address of each of the affiliates of Investment Group of Santa Barbara is 1485 East Valley Road, Suite L, Santa Barbara, CA 93108. |
(17) | Represents shares of Common Stock acquired in the PIPE Financing. Represents (a) 112,363 shares of Common Stock held of record by BNP Paribas New York Branch on behalf of Janus Henderson Global Technology and Innovation Portfolio and (b) 887,637 shares of Common Stock held of record by BNP Paribas New York Branch on behalf of Janus Henderson Global Technology and Innovation Fund. Based on information provided to the Company by the Selling Stockholder. Such shares may be deemed to be beneficially owned by Janus Capital Management LLC (“Janus”), an investment adviser registered under the Investment Advisers Act of 1940, who acts as investment adviser for the Fund and has the ability to make decisions with respect to the voting and disposition of the shares subject to the oversight of the board of directors of the Fund. Under the terms of its management contract with the Fund, Janus has overall responsibility for directing the investments of the Fund in accordance with the Fund’s investment objective, policies and limitations. Each Fund has one or more portfolio managers appointed by and serving at the pleasure of Janus who makes decisions with respect to the disposition of the Shares. The address for Janus is 151 Detroit Street, Denver, CO 80206. |
(18) | Represents shares of Common Stock acquired in the PIPE Financing. Represents (a) 141,438 shares of Common Stock held of record by Maverick Fund II, Ltd. and (b) 358,562 shares of Common Stock held of record by Maverick Fund USA, Ltd. Maverick Capital, Ltd. is an investment adviser registered as such with the Securities and Exchange Commission and, as such, may be deemed to have beneficial ownership of the shares of Common Stock through the investment discretion it exercises over the accounts of its clients, Maverick Fund II, Ltd. and Maverick Fund USA, Ltd. The business address of each of the affiliates of Maverick Capital is c/o Maverick Capital, Ltd., 1900 N. Pearl Street, 20th Floor, Dallas, TX 75201. |
(19) | Represents 500,000 shares of Common Stock acquired in the PIPE Financing. Represents (a) 3,085,401 shares of Common Stock held of record by MFS Mid Cap Growth Fund (including 452,972 shares of Common Stock acquired in the PIPE Financing), (b) 22,191 shares of Common Stock held of record by AST MFS Growth Allocation Portfolio (including 3,396 shares of Common Stock acquired in the PIPE Financing), (c) 190,119 shares of Common Stock held of record by AST Mid-Cap Growth Portfolio (including 29,748 shares of Common Stock acquired in the PIPE Financing) and (d) 92,136 shares of Common Stock held of record by MFS Variable Insurance Trust - MFS Mid Cap Growth Series (including 13,884 shares of Common Stock acquired in the PIPE Financing). The business address of each of the affiliates of MFS Investment Management is c/o MFS Investment Management, 111 Huntington Ave, Boston, MA 02199-7618. |
(20) | Represents shares of Common Stock acquired in the PIPE Financing. Represents (a) 1,273,239 shares of Common Stock held of record by T. Rowe Price Mid-Cap Growth Fund, Inc., (b) 260,346 shares of Common Stock held of record by T. Rowe Price Institutional Mid-Cap Equity Growth Fund, (c) 20,220 shares of Common Stock held of record by T. Rowe Price Mid-Cap Growth Portfolio, (d) 8,276 shares of Common Stock held of record by T. Rowe Price U.S. Equities Trust, (e) 66,127 shares of Common Stock held of record by Great-West Funds, Inc. - Great-West T. Rowe Price Mid Cap Growth Fund, (f) 90,991 shares of Common Stock held of record by TD Mutual Funds - TD U.S. Mid-Cap Growth Fund, (g) 241,702 shares of Common Stock held of record by MassMutual Select Funds - MassMutual Select Mid Cap Growth Fund, (h) 13,156 shares of Common Stock held of record by MML Series Investment Fund - MML Mid Cap Growth Fund, (i) 60,461 shares of Common Stock held of record by Brighthouse Funds Trust I - T. Rowe Price Mid Cap Growth Portfolio, (j) 21,566 shares of Common Stock held of record by Marriott International, Inc. Pooled Investment Trust for Participant Directed Accounts, (k) 183,731 shares of |
Common Stock held of record by T. Rowe Price U.S. Mid-Cap Growth Equity Trust, (l) 5,935 shares of Common Stock held of record by L’Oreal USA, Inc. Employee Retirement Savings Plan 47-1188068 United States $ - T. Rowe Price Associates, Inc, (m) 48,232 shares of Common Stock held of record by Costco 401(k) Retirement Plan, (n) 8,082 shares of Common Stock held of record by MassMutual Select Funds - MassMutual Select T. Rowe Price Small and Mid Cap Blend Fund, (o) 236 shares of Common Stock held of record by Saint-Gobain Corporation, (p) 77,629 shares of Common Stock held of record by T. Rowe Price Diversified Mid-Cap Growth Fund, Inc., (q) 9,114 shares of Common Stock held of record by The Bunting Family III, LLC, (r) 2,683 shares of Common Stock held of record by Seasons Series Trust - SA Multi-Managed Mid Cap Growth Portfolio, (s) 40,350 shares of Common Stock held of record by Lincoln Variable Insurance Products Trust - LVIP T. Rowe Price Structured Mid-Cap Growth Fund, (t) 46,036 shares of Common Stock held of record by Voya Partners, Inc. - VY T. Rowe Price Diversified Mid Cap Growth Portfolio, (u) 6,257 shares of Common Stock held of record by T. Rowe Price Tax-Efficient Equity Fund, (v) 14,369 shares of Common Stock held of record by Lincoln Variable Insurance Products Trust - LVIP Blended Mid Cap Managed Volatility Fund and (q) 1,262 shares of Common Stock held of record by Jeffrey LLC. The business address of each of the affiliates of T. Rowe Price is c/o T. Rowe Price Associates, Inc., 100 East Pratt Street, Baltimore, MD 21202. |
(21) | The disclosure with respect to the remaining selling securityholders is being made on an aggregate basis, as opposed to an individual basis, because their aggregate holdings are less than 1% of the outstanding shares of our Common Stock. Represents an aggregate of 375,000 shares of Common Stock beneficially owned by former directors of Dragoneer. The business address for such selling securityholders is c/o Dragoneer Investment Group, LLC, One Letterman Drive, Building D, Suite M500, San Francisco, California, 94129. |
• | Vehicle parts proliferation: |
• | Internal technology systems: |
• | Growing connected car capabilities: |
• | TaaS and other new business models: |
• | ADAS and diagnostics systems: |
• | Growing our customer base: |
• | Deepening relationships with existing customers: |
• | Expanding the breadth of our solutions: one-third of our collision repair customers have already adopted this subscription package solution. We intend to continuously launch new solutions to improve value delivery, and expand the breadth of our capabilities across the P&C insurance landscape. |
• | Broadening our network ecosystem: |
• | Growing our geographic footprint |
• | Pursuing acquisitions |
• | CCC Workflow: Our suite of workflow tools supports end-to-end two-way text communications. Our workflow solutions leverage a sophisticated rules engine to customize routing for escalations, review, and approval processes. Our network management capability powers insurance DRPs, enabling insurers to seamlessly connect and collaborate with repair facilities and other companies to provide accurate and timely information about a claim flow from the right party at the right time. |
• | CCC Estimating: Our insurance automotive repair estimating solution is built on CCC’s proprietary estimating database that has been cultivated for decades to deliver best-in-class AI-powered estimating solution which uses AI machine learning and estimating logic to predict repair requirements, suggest estimate lines, and generate fast baseline estimates. Our estimating solutions accelerate auto physical damage estimation to reduce costs and cycle time for our customers. |
• | CCC Total Loss: Total loss solutions enable our insurance customers to identify, value, and resolve total loss automotive claims digitally. We deliver valuations representing a vehicle’s fair market value based on CCC’s market-driven valuation methodology and provide insurers with information to make total loss determinations. Once a total loss has been identified, we support our carrier customers in managing lender payoff requests, letters of guarantee, lien and title resolution, and signature collection. Throughout the process, our mobile solutions deliver a seamless customer experience integrated into CCC’s holistic workflow suite. |
• | CCC AI and Analytics: AI-enabled solutions. All of our core software offerings are supported by Analytics solutions that allow our customers to benchmark and manage their business performance across key performance indicators. |
• | CCC Casualty: |
• | CCC Estimating |
• | CCC Network Management: We provide software solutions that power collaboration between repairers and insurers. Our technology facilitates the majority of the automotive insurance DRP in the U.S. Participating repairers benefit from our connected technology platform that allows them to receive repair assignments and collaborate with partner insurers throughout the repair process, delivering on program metrics that drive their business. We also provide tools that allow repair Multi Store Owners (“MSOs”) to manage performance, metrics, and compliance across their repair shop network. |
• | CCC Repair Workflow: Repair workflow is the industry’s leading repair management tool that accelerates productivity and simplifies operations for thousands of repair facilities. Repairers can |
schedule and track vehicle repair status, assign tasks, and manage productivity across their operation. Configurable dashboards provide visibility into performance. Repairers can also streamline repair management leveraging CCC’s real-time parts ordering platform, selecting parts from multiple vendors through a single cart and invoice. Customer-to-shop |
• | CCC Repair Quality: We provide advanced solutions to help repairers deliver quality repairs. Our repair procedures provide technicians with a single source for data-driven insights to assist them in conducting thorough, consistent repairs, reducing the need for multiple subscriptions and enabling access to current OEM guidelines and processes. Our checklist solutions enable documentation of standard operating procedures and tracking of performance which allows shop managers to identify areas for improvement. CCC’s diagnostics solutions simplify scan initiation and reporting with integrated functionality for all scan types (OEM Direct, Technician Assisted, or Aftermarket), which saves repairers time on pre, post, and calibration scans. |
• | CCC Parts Solutions |
• | CCC Automotive Manufacturer Solutions up-to-date |
• | CCC Lender Solutions |
• | Ease of implementation |
• | Flexibility |
• | Innovation |
• | Security and Quality |
• | Availability and Uptime |
• | Internally developed software these in-house technology programs will be supported by large-scale consulting firms. |
• | P&C insurance software vendors |
• | Other ecosystem software vendors e-commerce platforms. |
Quarter Ending |
2019 |
2020 |
2021 |
|||||||||||
Software NDR |
March 31 | 103 | % | 105 | % | 106 | % | |||||||
June 30 | 105 | % | 103 | % | 110 | % | ||||||||
September 30 | 107 | % | 103 | % | ||||||||||
December 31 | 107 | % | 103 | % |
Quarter Ending |
2019 |
2020 |
2021 |
|||||||||||
Software GDR |
March 31 | 98 | % | 98 | % | 98 | % | |||||||
June 30 | 98 | % | 98 | % | 98 | % | ||||||||
September 30 | 98 | % | 98 | % | ||||||||||
December 31 | 98 | % | 98 | % |
• | Conversion and implementation of new customers: |
• | Long-term customer relationships: end-markets we serve, and these relationships are a key component of our success given the long-term nature of our contracts and the interconnectedness of our network. We generate revenue through the sale of software subscriptions and our average contract is approximately three to five years in duration. As of June 30, 2021, our national carrier customers included 18 of the top 20 automotive insurers, with average customer relationships spanning more than 10 years, and numerous exclusive arrangements. |
• | Expansion of solution adoption from existing customers: go-to-market |
• | Investment in R&D: |
solutions for the P&C insurance economy. We believe that maintaining our software solution leadership is imperative to our growth plan. As a result, we intend to continue making significant investments in research and development to improve and expand our software solutions. Our research and development expenses totaled $61.9 million and $55.3 million in the six months ended June 30, 2021 and 2020, respectively, $109.5 million, $114.0 million and $108.2 million in the years ended December 31, 2020, 2019 and 2018, respectively. We expect that research and development will remain a key investment area for the foreseeable future. |
• | Investment in Platform, Privacy, and Security: |
• | Investment in Sales and Marketing: COVID-19 pandemic. As the business continues to grow, we expect sales and marketing expenses to increase in absolute dollars for the foreseeable future. |
Three Months Ended June 30, |
Change |
|||||||||||||||
(dollar amounts in thousands, except share and per share data) |
2021 |
2020 |
$ |
% |
||||||||||||
Revenue |
$ | 166,789 | $ | 150,716 | $ | 16,073 | 10.7 | % | ||||||||
Cost of revenue, exclusive of amortization of acquired technologies |
38,932 | 43,408 | (4,476 | ) | -10.3 | % | ||||||||||
Amortization of acquired technologies |
6,580 | 6,574 | 6 | 0.1 | % | |||||||||||
|
|
|
|
|||||||||||||
Cost of revenue |
45,512 | 49,982 | (4,470 | ) | -8.9 | % | ||||||||||
|
|
|
|
|||||||||||||
Gross profit |
121,277 | 100,734 | 20,543 | 20.4 | % | |||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
31,253 | 27,772 | 3,481 | 12.5 | % | |||||||||||
Selling and marketing |
21,551 | 17,702 | 3,849 | 21.7 | % | |||||||||||
General and administrative |
28,394 | 21,566 | 6,828 | 31.7 | % | |||||||||||
Amortization of intangible assets |
18,078 | 18,078 | — | — | % | |||||||||||
|
|
|
|
|||||||||||||
Total operating expenses |
99,276 | 85,118 | 14,158 | 16.6 | % | |||||||||||
|
|
|
|
|||||||||||||
Operating income |
22,001 | 15,616 | 6,385 | 40.9 | % | |||||||||||
Other income (expense): |
||||||||||||||||
Interest expense |
(18,903 | ) | (18,643 | ) | (260 | ) | (1.4 | )% | ||||||||
Gain on change in fair value of interest rate swaps |
3,089 | 620 | 2,469 | 398.2 | % | |||||||||||
Other income, net |
4 | 115 | (111 | ) | (96.5 | )% | ||||||||||
|
|
|
|
|||||||||||||
Total other income (expense) |
(15,810 | ) | (17,908 | ) | 2,098 | 11.7 | % | |||||||||
Income (loss) before income taxes |
6,191 | (2,292 | ) | 8,483 | NM | |||||||||||
Income tax (provision) benefit |
(2,375 | ) | 331 | (2,706 | ) | NM | ||||||||||
|
|
|
|
|||||||||||||
Net income (loss) |
$ | 3,816 | $ | (1,961 | ) | $ | 5,777 | NM | ||||||||
|
|
|
|
|||||||||||||
Net income (loss) per share attributable to Class A and Class B common stockholders |
||||||||||||||||
Basic |
$ | 2.57 | $ | (1.32 | ) | |||||||||||
Diluted |
$ | 2.48 | $ | (1.32 | ) | |||||||||||
Weighted-average shares used in computing net income (loss) per share attributable to Class A and Class B common stockholders: |
||||||||||||||||
Basic |
1,484,156 | 1,480,262 | ||||||||||||||
Diluted |
1,537,767 | 1,480,262 |
Six Months Ended June 30, |
Change |
|||||||||||||||
(dollar amounts in thousands, except share and per share data) |
2021 |
2020 |
$ |
% |
||||||||||||
Revenue |
$ | 324,578 | $ | 309,924 | $ | 14,654 | 4.7 | % | ||||||||
Cost of revenue, exclusive of amortization of acquired technologies |
76,945 | 91,795 | (14,850 | ) | -16.2 | % | ||||||||||
Amortization of acquired technologies |
13,160 | 13,149 | 11 | 0.1 | % | |||||||||||
|
|
|
|
|||||||||||||
Cost of revenue |
90,105 | 104,944 | (14,839 | ) | -14.1 | % | ||||||||||
|
|
|
|
|||||||||||||
Gross profit |
234,473 | 204,980 | 29,493 | 14.4 | % | |||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
61,877 | 55,315 | 6,562 | 11.9 | % | |||||||||||
Selling and marketing |
40,968 | 39,181 | 1,787 | 4.6 | % | |||||||||||
General and administrative |
66,233 | 44,566 | 21,667 | 48.6 | % | |||||||||||
Amortization of intangible assets |
36,155 | 36,155 | — | 0.0 | % | |||||||||||
|
|
|
|
|||||||||||||
Total operating expenses |
205,233 | 175,217 | 30,016 | 17.1 | % | |||||||||||
|
|
|
|
|||||||||||||
Operating income |
29,240 | 29,763 | (523 | ) | -1.8 | % | ||||||||||
Other income (expense): |
||||||||||||||||
Interest expense |
(37,669 | ) | (37,800 | ) | 131 | 0.3 | % | |||||||||
Gain (loss) on change in fair value of interest rate swaps |
6,366 | (20,527 | ) | 26,893 | NM | |||||||||||
Loss on early extinguishment of debt |
— | (8,615 | ) | 8,615 | 100.0 | % | ||||||||||
Other income, net |
91 | 255 | (164 | ) | -64.3 | % | ||||||||||
Total other income (expense) |
(31,212 | ) | (66,687 | ) | 35,475 | 53.2 | % | |||||||||
Loss before income taxes |
(1,972 | ) | (36,924 | ) | 34,952 | 94.7 | % | |||||||||
Income tax benefit |
704 | 9,711 | (9,007 | ) | -92.8 | % | ||||||||||
|
|
|
|
|||||||||||||
Net loss |
$ | (1,268 | ) | $ | (27,213 | ) | $ | 25,945 | 95.3 | % | ||||||
|
|
|
|
|||||||||||||
Net loss per share attributable to Class A and Class B common stockholders—basic and diluted |
$ | (0.85 | ) | $ | (18.39 | ) | ||||||||||
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders— basic and diluted |
1,483,634 | 1,479,918 |
Year Ended December 31, |
Change |
|||||||||||||||
(dollar amounts in thousands, except share and per share data) |
2020 |
2019 |
$ |
% |
||||||||||||
Revenue |
$ | 633,063 | $ | 616,084 | $ | 16,979 | 2.8 | % | ||||||||
Cost of revenue, exclusive of amortization and impairment of acquired technologies |
182,414 | 191,868 | (9,454 | ) | -4.9 | % | ||||||||||
Amortization of acquired technologies |
26,303 | 27,797 | (1,494 | ) | -5.4 | % | ||||||||||
Impairment of acquired technologies |
— | 5,984 | (5,984 | ) | N/M | |||||||||||
|
|
|
|
|
|
|||||||||||
Cost of revenue |
208,717 | 225,649 | (16,932 | ) | -7.5 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Gross margin |
424,346 | 390,435 | 33,911 | 8.7 | % | |||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
109,508 | 114,005 | (4,497 | ) | -3.9 | % | ||||||||||
Selling and marketing |
74,710 | 82,109 | (7,399 | ) | -9.0 | % | ||||||||||
General and administrative |
90,838 | 78,128 | 12,710 | 16.3 | % | |||||||||||
Amortization of intangible assets |
72,310 | 81,329 | (9,019 | ) | -11.1 | % | ||||||||||
Impairment |
— | 201,066 | (201,066 | ) | NM | |||||||||||
|
|
|
|
|
|
|||||||||||
Total operating expenses |
347,366 | 556,637 | (209,271 | ) | -37.6 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Operating income (loss) |
76,980 | (166,202 | ) | 243,182 | -146.3 | % | ||||||||||
Other income (expense): |
||||||||||||||||
Interest expense |
(77,003 | ) | (89,475 | ) | 12,472 | -13.9 | % | |||||||||
Loss on change in fair value of interest rate swaps |
(13,249 | ) | (22,432 | ) | 9,183 | -40.9 | % | |||||||||
Loss on early extinguishment of debt |
(8,615 | ) | — | (8,615 | ) | NM | ||||||||||
Other income, net |
332 | 476 | (144 | ) | -30.3 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Total other income (expense) |
(98,535 | ) | (111,431 | ) | 12,896 | -11.6 | % | |||||||||
Loss before income taxes |
(21,555 | ) | (277,633 | ) | 256,078 | -92.2 | % | |||||||||
Income tax benefit |
4,679 | 67,293 | (62,614 | ) | -93.0 | % | ||||||||||
|
|
|
|
|
|
|||||||||||
Net loss |
$ | (16,876 | ) | $ | (210,340 | ) | $ | 193,464 | -92.0 | % | ||||||
|
|
|
|
|
|
|||||||||||
Net loss per share attributable to Class A and Class B common stockholders—basic and diluted |
$ | (11.40 | ) | $ | (142.28 | ) | ||||||||||
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders—basic and diluted |
1,480,296 | 1,478,350 |
Year Ended December 31, |
Change |
|||||||||||||||
(dollar amounts in thousands, except share and per share data) |
2019 |
2018 |
$ |
% |
||||||||||||
Revenue |
$ | 616,084 | $ | 569,772 | $ | 46,312 | 8.1 | % | ||||||||
Cost of revenue: |
||||||||||||||||
Cost of revenue, exclusive of amortization and impairment of acquire technologies |
191,868 | 184,418 | 7,450 | 4.0 | % | |||||||||||
Amortization of acquired technologies |
27,797 | 28,379 | (582 | ) | -2.1 | % | ||||||||||
Impairment of acquired technologies |
5,984 | — | 5,984 | NM | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total cost of revenue |
225,649 | 212,797 | 12,852 | 6.0 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Gross margin |
390,435 | 356,975 | 33,460 | 9.4 | % | |||||||||||
Operating expenses: |
||||||||||||||||
Research and development |
114,005 | 108,169 | 5,836 | 5.4 | % | |||||||||||
Selling and marketing |
82,109 | 73,830 | 8,279 | 11.2 | % | |||||||||||
General and administrative |
78,128 | 65,728 | 12,400 | 18.9 | % | |||||||||||
Amortization of intangible assets |
81,329 | 84,335 | (3,006 | ) | -3.6 | % | ||||||||||
Impairment |
201,066 | — | 201,066 | NM | ||||||||||||
|
|
|
|
|
|
|||||||||||
Total operating expenses |
556,637 | 332,062 | 224,575 | 67.6 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Operating (loss) income |
(166,202 | ) | 24,913 | (191,115 | ) | -767.1 | % | |||||||||
Interest expense |
(89,475 | ) | (90,329 | ) | 854 | -0.9 | % | |||||||||
(Loss) gain on change in fair value of interest rate swaps |
(22,432 | ) | 6,890 | (29,322 | ) | -425.6 | % | |||||||||
Other income, net |
476 | 472 | 4 | 0.8 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Total other expense |
(111,431 | ) | (82,967 | ) | (28,464 | ) | 34.3 | % | ||||||||
|
|
|
|
|
|
|||||||||||
Pretax loss |
(277,633 | ) | (58,054 | ) | (219,579 | ) | 378.2 | % | ||||||||
Income tax benefit |
67,293 | 3,023 | 64,270 | 2126.0 | % | |||||||||||
|
|
|
|
|
|
|||||||||||
Net loss |
$ | (210,340 | ) | $ | (55,031 | ) | $ | (155,309 | ) | 282.2 | % | |||||
|
|
|
|
|
|
|||||||||||
Net loss attributable to Class A and Class B common stockholders—basic and diluted: |
$ | (142.28 | ) | $ | (37.22 | ) | ||||||||||
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders—basic and diluted: |
1,478,350 | 1,478,373 |
Six Months Ended June 30 |
Year ended December 31, |
|||||||||||||||||||
(amounts in thousands) |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||
Gross Profit |
$ | 234,473 | $ | 204,980 | $ | 424,346 | $ | 390,435 | $ | 356,975 | ||||||||||
First Party Clinical Services—Gross Profit |
— | (2,390 | ) | (3,429 | ) | (6,118 | ) | (12,277 | ) | |||||||||||
Amortization of acquired technologies |
13,160 | 13,149 | 26,303 | 27,797 | 28,379 | |||||||||||||||
Impairment of acquired technologies |
— | — | — | 5,984 | — | |||||||||||||||
Stock-based compensation |
394 | 239 | 494 | 485 | 454 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Adjusted Gross Profit |
$ | 248,027 | $ | 215,978 | $ | 447,714 | $ | 418,583 | $ | 373,531 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Gross Profit Margin |
72 | % | 66 | % | 67 | % | 63 | % | 63 | % | ||||||||||
Adjusted Gross Profit Margin |
76 | % | 70 | % | 75 | % | 73 | % | 72 | % |
Three Months Ended June 30, |
Six Months Ended June 30, |
Year ended December 31, |
||||||||||||||||||||||||||
(dollar amounts in thousands) |
2021 |
2020 |
2021 |
2020 |
2020 |
2019 |
2018 |
|||||||||||||||||||||
Net income (loss) |
$ | 3,816 | $ | (1,961 | ) | $ | (1,268 | ) | $ | (27,213 | ) | $ | (16,876 | ) | $ | (210,340 | ) | $ | (55,031 | ) | ||||||||
Interest expense |
18,903 | 18,643 | 37,669 | 37,800 | 77,003 | 89,475 | 90,329 | |||||||||||||||||||||
Income tax provision (benefit) |
2,375 | (331 | ) | (704 | ) | (9,711 | ) | (4,679 | ) | (67,293 | ) | (3,023 | ) | |||||||||||||||
Amortization of intangible assets |
18,078 | 18,078 | 36,155 | 36,155 | 72,310 | 81,329 | 84,335 | |||||||||||||||||||||
Amortization of acquired technologies—Cost of revenue |
6,580 | 6,574 | 13,160 | 13,149 | 26,303 | 27,797 | 28,379 | |||||||||||||||||||||
Depreciation and amortization related to software, equipment and property |
5,314 | 4,243 | 10,467 | 8,543 | 17,749 | 18,391 | 14,700 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
EBITDA |
55,066 | 45,246 | 95,479 | 58,723 | 171,810 | (60,641 | ) | 159,689 | ||||||||||||||||||||
Loss (gain) on change in fair value of interest rate swaps |
(3,089 | ) | (620 | ) | (6,366 | ) | 20,527 | 13,249 | 22,432 | (6,890 | ) | |||||||||||||||||
Impairment charge |
— | — | — | — | — | 207,050 | — | |||||||||||||||||||||
Stock-based compensation |
2,883 | 2,371 | 15,537 | 5,601 | 2,883 | 7,710 | 7,542 | |||||||||||||||||||||
Loss on early extinguishment of debt |
— | — | — | 8,615 | — | — | — | |||||||||||||||||||||
Business Combination Transaction costs |
1,953 | — | 4,955 | — | 1,953 | — | — | |||||||||||||||||||||
Lease abandonment |
925 | — | 1,850 | — | 925 | |||||||||||||||||||||||
Lease overlap costs |
909 | — | 1,817 | — | 909 | |||||||||||||||||||||||
Net costs related to divestiture |
1,494 | — | 2,266 | — | 1,494 | — | — | |||||||||||||||||||||
First Party Clinical Services—Revenue |
— | (6,603 | ) | — | (18,255 | ) | — | (46,042 | ) | (51,635 | ) | |||||||||||||||||
First Party Clinical Services—Cost of revenue |
— | 6,462 | — | 15,865 | — | 39,924 | 39,357 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted EBITDA |
$ | 60,141 | $ | 46,856 | $ | 115,538 | $ | 91,076 | $ | 202,804 | $ | 170,433 | $ | 148,063 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, |
||||||||
(dollar amounts in thousands) |
2021 |
2020 |
||||||
Net cash provided by operating activities |
$ | 59,820 | $ | 23,776 | ||||
Net cash used in investing activities |
(23,396 | ) | (13,072 | ) | ||||
Net cash (used in) provided by financing activities |
(139,962 | ) | 2,160 | |||||
Net effect of exchange rate change |
(74 | ) | (46 | ) | ||||
|
|
|
|
|||||
Change in cash and cash equivalents |
$ | (103,612 | ) | $ | 12,818 | |||
|
|
|
|
Year Ended December 31, |
||||||||||||
(dollar amounts in thousands) |
2020 |
2019 |
2018 |
|||||||||
Net cash provided by operating activities |
$ | 103,943 | $ | 66,301 | $ | 72,286 | ||||||
Net cash used in investing activities |
(30,667 | ) | (21,055 | ) | (20,179 | ) | ||||||
Net cash used in financing activities |
(4,421 | ) | (9,428 | ) | (60,100 | ) | ||||||
Net effect of exchange rate change |
62 | (70 | ) | (77 | ) | |||||||
|
|
|
|
|
|
|||||||
Change in cash, cash equivalents and restricted cash |
$ | 68,917 | $ | 35,748 | $ | (8,070 | ) | |||||
|
|
|
|
|
|
• | Revenue Recognition |
• | Valuation of Goodwill and Intangible Assets |
• | Stock-based Compensation |
• | Fair Value of Common Stock—As there has been no public market for our common stock, for all periods included in our financial statements, fair values of the shares of common stock underlying our stock-based awards were estimated on each grant date by our board of directors. Our board of |
directors, with input from management considered, among other things, valuations of our common stock, which were prepared in accordance with the guidance provided by the American Institute of Certified Public Accountants 2013 Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation as well as the Advent Transaction for grants in 2017. |
• | Expected Term—The expected term represents the period that stock-based awards are expected to be outstanding and, for time-based awards, is determined using the simplified method that uses the weighted average of the time-to-vesting |
• | Expected Volatility—Since we are privately held and do not have any trading history for our common stock, the expected volatility was estimated based on the average volatility for comparable publicly traded companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on their similar size, stage in the life cycle or area of specialty. |
• | Risk-Free Interest Rate—The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of awards. |
• | Expected Dividend Yield—Historically, we have not paid regular dividends on our common stock and have no plans to pay dividends on our common stock on a regular basis. We do not have a dividend policy. Therefore, we used an expected dividend yield of zero. |
• | Githesh Ramamurthy, Chairman and Chief Executive Officer |
• | Brian Herb, Executive Vice President, Chief Financial and Administrative Officer |
• | Barrett Callaghan, General Manager and Senior Vice President of Insurance Services , . |
Name and Principal Position |
Year |
Salary(1) ($) |
Bonus(2) ($) |
Stock Awards(3) ($) |
Option Awards(4) ($) |
Non-Equity Incentive Plan Compensation ($) |
All Other Compensation(5) ($) |
Total ($) |
||||||||||||||||||||||||
Githesh Ramamurthy Chairman and Chief Executive Officer |
2020 | 782,661 | 704,590 | 15,723 | 1,502,974 | |||||||||||||||||||||||||||
Brian Herb Executive Vice President, Chief Financial and Administrative Officer |
2020 | 473,846 | 300,000 | 1,560,000 | 1,494,480 | 247,500 | 20,805 | 4,096,631 | ||||||||||||||||||||||||
Barrett Callaghan GM and SVP, Insurance Services |
2020 | 377,478 | 459,840 | 212,390 | 16,545 | 1,066,253 |
(1) | The amounts shown in this column reflect all salary earned during the fiscal year. Mr. Herb was hired by CCC as Executive Vice President, Chief Financial and Administrative Officer on February 18, 2020. |
(2) | The amount in this column represents the $300,000 sign-on cash bonus paid to Mr. Herb in connection with the commencement of his employment with CCC as Executive Vice President, Chief Financial and Administrative Officer. |
(3) | The amount in this column represents the grant date fair value of the 1,000 unrestricted shares of common stock of CCC awarded to Mr. Herb in connection with the commencement of his employment with CCC. Valuation of the unrestricted common stock of CCC was determined based on the fair market value of a share of CCC common stock on the grant date. |
(4) | These amounts represent the aggregate grant date fair value for option awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, or ASC 718. A discussion of CCC’s methodology for determining grant date fair value may be found in Note 17 to our consolidated financial statements included elsewhere in this prospectus for a discussion of all assumptions made by us in determining the grant-date fair value of our equity awards. |
(5) | All Other Compensation for 2020 for the NEOs is comprised of the following: |
All Other Compensation Table |
Year |
Individual Supplemental Disability Premiums ($) |
401(K) Match ($) |
Health Club Reimbursement ($) |
Health Club Gross Up ($) |
Merchandise Mart Parking Reimbursement ($) |
Merchandise Mart Parking Gross Up ($) |
Loan Interest Reimbursement (1) ($) |
Loan Interest Reimbursement Gross Up ($) |
Total ($) |
||||||||||||||||||||||||||||||
Githesh Ramamurthy Chairman and Chief Executive Officer |
2020 | 5,100 | 8,250 | 122 | 44 | 1,560 | 646 | 15,723 | ||||||||||||||||||||||||||||||||
Brian Herb Executive Vice President & Chief Financial Officer |
2020 | 738 | 8,250 | 1,300 | 1,034 | 5,282 | 4,201 | 20,805 | ||||||||||||||||||||||||||||||||
Barrett Callaghan GM & SVP, Insurance Services |
2020 | 4,396 | 8,250 | 1,197 | 496 | 1,560 | 647 | 16,545 |
(1) | These amounts represent a $5,282 payment to Mr. Herb in September of 2020 for reimbursement of loan interest expense related to his borrowings for tax obligations in connection with the 2020 stock grant and $4,201 for a tax gross up on this reimbursement. |
Option Awards(1) |
||||||||||||||||||||||||
Number of Securities Underlying Unexercised Options |
Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) |
Option Exercise Price ($) |
Option Expiration Date |
|||||||||||||||||||||
Name |
Grant Date |
Exercisable (#) |
Unexercisable (#) |
|||||||||||||||||||||
Githesh Ramamurthy |
7/10/2017 | (2) | 16,500 | 11,000 | $ | 966.18 | 7/10/2027 | |||||||||||||||||
Chairman and Chief Executive Officer |
7/10/2017 | (3) | 27,500 | $ | 966.18 | 7/10/2027 | ||||||||||||||||||
Brian Herb |
4/1/2020 | (2) | 0 | 1,625 | $ | 1,560.00 | 4/1/2030 | |||||||||||||||||
Executive Vice President & Chief Financial Officer |
4/1/2020 | (3) | 1,625 | $ | 1,560.00 | 4/1/2030 | ||||||||||||||||||
Barrett Callaghan |
7/10/2017 | (2) | 1,500 | 1,000 | $ | 966.18 | 7/10/2027 | |||||||||||||||||
General Manager & Senior Vice President, Insurance Services |
7/10/2017 | (3) | 2,500 | $ | 966.18 | 7/10/2027 | ||||||||||||||||||
4/1/2020 | (2) | 0 | 500 | $ | 1,560.00 | 4/1/2030 | ||||||||||||||||||
4/1/2020 | (3) | 500 | $ | 1,560.00 | 4/1/2030 |
(1) | All of the outstanding equity awards were granted under the 2017 Stock Option Plan of Cypress Holdings, Inc. (the “2017 Stock Option Plan”). In connection with the Business Combination, each equity award of CCC outstanding immediately prior to the Effective Time was exchanged for comparable equity awards that will be settled or exercisable for shares of New CCC Common Stock. |
(2) | The options in these rows vest in equal annual installments over the five-year period beginning on the grant date, subject to the optionholder’s continued employment with CCC or one of its subsidiaries through the applicable vesting date. |
(3) | The options in these rows vest based on the return on investment received by certain of CCC’s shareholders in a merger, sale or other similar transaction or based upon CCC’s valuation on an initial public offering assuming all of such investors’ shares had been sold (a “Sponsor Return”), with (a) 33.34% vesting upon a Sponsor Return of 2.0x, (b) 33.33% vesting upon a Sponsor Return of 2.5x and (c) 33.33% vesting upon a Sponsor Return of 3.0x; subject in each case to the optionholder remaining employed by CCC or one of its subsidiaries through the applicable vesting date. In addition, any portion of an option that does not vest at the time of our initial public offering because the performance hurdle has not been achieved shall convert to a Time-vested Option (as defined below) and shall vest as to 1/12th of such converted time-vested option on each three-month anniversary of the date of the initial public offering. The Performance-vested Options were deemed to vest on the Closing of the Business Combination as if the transaction had been an initial public offering and, based on the fair market value of the common stock of CCC as of the Closing of the Business Combination, 100% of the Performance-vested Options became vested on the Closing of the Business Combination and 0% converted to Time-vested Options. |
• | Mr. Ramamurthy received 90% of his target cash incentive (75% company performance and 120% individual performance multiplier). |
• | Mr. Herb received 90% of his target cash incentive (75% company performance and 120% individual performance multiplier). |
• | Mr. Callaghan received 113% of his target cash incentive (75% company performance and 150% individual performance multiplier). |
• | Time-Vested Stock Options |
• | Performance-Vested Stock Options |
Name |
Fees Earned or Paid in Cash ($)(1) |
Option Awards ($)(2) |
Total ($) |
|||||||||
Jim Peck |
60,000 | — | 60,000 | |||||||||
Eileen Schloss |
22,011 | 229,920 | 251,931 | |||||||||
William Ingram |
11,902 | — | 11,902 | |||||||||
Christopher Egan(4) |
||||||||||||
Eric Wei(4) |
||||||||||||
Steve Puccinelli(4) |
||||||||||||
David Yuan(4) |
||||||||||||
Lauren Young(4) |
(1) | Represents the $15,000 quarterly retainer earned by each of our non-employee directors during 2020 for services as a director. Eileen Schloss was appointed to the CCC Board on August 19, 2020, and William Ingram was appointed to the CCC Board on October 20, 2020. |
(2) | The amounts in this column represent the aggregate grant-date fair value of option awards granted to each non-employee director, computed in accordance with FASB ASC Topic 718. See Note 16 to CCC’s audited consolidated financial statements included elsewhere in this prospectus for a discussion of all assumptions made by us in determining the grant-date fair value of our equity awards. The aggregate number of options held by each non-employee director as of December 31, 2020 were: Mr. Peck: 400, Ms. Schloss: 500. |
(3) | Mr. Peck resigned from the CCC Board as of January 28, 2021. |
(4) | These non-employee directors did not receive compensation in 2020 for services provided as members of the CCC Board. |
Name |
Age |
Position | ||
Githesh Ramamurthy | 60 | Chief Executive Officer and Chairman | ||
Brian Herb | 48 | Executive Vice President, Chief Financial and Administrative Officer | ||
Barrett Callaghan | 51 | Executive Vice President, Markets and Customer Success | ||
Mary Jo Prigge | 63 | Executive Vice President, Chief Service Delivery Officer | ||
John Goodson | 57 | Executive Vice President, Chief Technology Officer | ||
Marc Fredman | 43 | Senior Vice President, Chief Strategy Officer | ||
Shivani Govil | 50 | Senior Vice President, Chief Product Officer | ||
Steven G. Puccinelli | 62 | Director | ||
William Ingram | 64 | Director | ||
David Yuan | 46 | Director | ||
Eileen Schloss | 68 | Director | ||
Teri Williams | 63 | Director | ||
Christopher Egan | 45 | Director | ||
Eric Wei | 45 | Director | ||
Lauren Young | 38 | Director |
• | assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent auditors; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; |
• | pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; |
• | meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our chief executive officer’s compensation, evaluating our chief executive officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our chief executive officer’s based on such evaluation; |
• | reviewing and making recommendations to our board of directors with respect to the compensation, and any incentive compensation and equity based plans that are subject to board approval of all of our other officers; |
• | reviewing our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; |
• | producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for appointment at the annual general meeting or to fill vacancies on the board of directors; |
• | developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines; |
• | coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and |
• | reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary. |
• | attract, retain and motivate senior management leaders who are capable of advancing CCC’s mission and strategy and, ultimately, creating and maintaining its long-term equity value; |
• | seek to pay competitive cash compensation at the market median of our peer group and in the first quartile for total compensation including long term compensation; |
• | reward senior management in a manner aligned with CCC’s financial performance; and |
• | align senior management’s interests with CCC’s equity owners’ long-term interests through equity participation and ownership. |
• | 1% of the total number of shares of our New CCC Common Stock then outstanding; or |
• | the average weekly reported trading volume of our New CCC Common Stock during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale. |
• | the issuer of the securities that was formerly a shell company has ceased to be a shell company; |
• | the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act; |
• | the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding twelve months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and |
• | at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company. |
• | an individual who is a citizen or resident of the United States; |
• | a corporation (or any other entity treated as a corporation for United States federal income tax purposes) that is created or organized in or under the laws of the United States, any state thereof or the District of Columbia; |
• | an estate the income of which is subject to United States federal income taxation regardless of its source; or |
• | a trust if it (i) is subject to the primary supervision of a court within the United States and one or more United States persons have the authority to control all substantial decisions of the trust or (ii) has a valid election in effect under applicable United States Treasury regulations to be treated as a United States person. |
• | the gain is effectively connected with a trade or business of the non-U.S. holder in the United States (and, if required by an applicable income tax treaty, is attributable to a United States permanent establishment of the non-U.S. holder); |
• | the non-U.S. holder is an individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or |
• | we are or have been a “United States real property holding corporation” for United States federal income tax purposes and certain other conditions are met. |
• | purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; |
• | ordinary brokerage transactions and transactions in which the broker solicits purchasers; |
• | block trades in which the broker-dealer so engaged will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction; |
• | an over-the-counter |
• | through trading plans entered into by a Selling Holder pursuant to Rule 10b5-1 under the Exchange Act that are in place at the time of an offering pursuant to this prospectus and any applicable prospectus supplement hereto that provide for periodic sales of their securities on the basis of parameters described in such trading plans; |
• | through one or more underwritten offerings on a firm commitment or best efforts basis; |
• | settlement of short sales entered into after the date of this prospectus; |
• | agreements with broker-dealers to sell a specified number of the securities at a stipulated price per share or warrant; |
• | distribution to employees, members, limited partners or stockholders of the Selling Holders; |
• | by pledge to secured debts and other obligations; |
• | delayed delivery arrangements; |
• | in “at the market” offerings, as defined in Rule 415 under the Securities Act, at negotiated prices, at prices prevailing at the time of sale or at prices related to such prevailing market prices, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange or other similar offerings through sales agents; |
• | directly to purchasers, including through a specific bidding, auction or other process or in privately negotiated transactions; |
• | through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |
• | through a combination of any of the above methods of sale; or |
• | any other method permitted pursuant to applicable law. |
• | the specific securities to be offered and sold; |
• | the names of the Selling Holders; |
• | the respective purchase prices and public offering prices, the proceeds to be received from the sale, if any, and other material terms of the offering; |
• | settlement of short sales entered into after the date of this prospectus; |
• | the names of any participating agents, broker-dealers or underwriters; and |
• | any applicable commissions, discounts, concessions and other items constituting compensation from the Selling Holders. |
Page |
||||
Audited Financial Statements of Dragoneer Growth Opportunities Corp. |
||||
F-2 | ||||
F-3 | ||||
F-4 | ||||
F-5 | ||||
F-6 | ||||
F-7 | ||||
F-25 | ||||
F-26 | ||||
F-27 | ||||
F-28 | ||||
F-29 | ||||
Audited Consolidated Financial Statements of Cypress Holdings, Inc. |
||||
F-47 | ||||
F-48 | ||||
F-49 | ||||
F-50 | ||||
F-51 | ||||
F-52 | ||||
F-80 | ||||
F-82 | ||||
F-84 | ||||
F-86 | ||||
F-88 |
ASSETS |
||||
Current assets |
||||
Cash |
$ | |||
Prepaid expenses |
||||
Total Current Assets |
||||
Cash held in Trust Account |
||||
TOTAL ASSETS |
$ |
|||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
||||
Current liabilities |
||||
Accrued expenses |
$ | |||
Advance from related party |
||||
Total Current Liabilities |
||||
FPA liability |
||||
Warrant liability |
||||
Deferred underwriting fee payable |
||||
Total Liabilities |
||||
Commitments and Contingencies |
||||
Class A ordinary shares subject to possible redemption, |
||||
Shareholders’ Equity |
||||
Preference shares, $ |
||||
Class A ordinary shares, $ |
||||
Class B ordinary shares, $ |
||||
Additional paid-in capital |
||||
Accumulated deficit |
( |
) | ||
Total Shareholders’ Equity |
||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
$ |
|||
Formation and operating costs |
$ | |||
Loss from Operations |
( |
) | ||
Other Income (expense): |
||||
Change in fair value of warrant liability |
( |
) | ||
Change in fair value of FPA |
( |
) | ||
Compensation expense resulting from issuance of private placement warrants |
( |
) | ||
Offering costs allocated to warrant liabilities |
( |
) | ||
Total Other Income (expense) |
$ |
( |
) | |
Weighted average shares outstanding of Class A redeemable ordinary shares |
||||
Basic and diluted net income per share, Class A |
$ |
|||
Weighted average shares outstanding of Class B non-redeemable ordinary shares |
||||
Basic and diluted net loss per share, Class B |
$ |
( |
) | |
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid in |
Accumulated |
Total Shareholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity |
||||||||||||||||||||||
Balance — July 3, 2020 (inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||
Issuance of Class B ordinary shares to Sponsor |
— | — | — |
|||||||||||||||||||||||||
Sale of 69,000,000 Units, net of underwriting discounts and offering costs and Public Warrant fair value |
— | — | — | |||||||||||||||||||||||||
Class A ordinary shares subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | ( |
) | ||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
Balance — December 31, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Cash Flows from Operating Activities: |
||||
Net loss |
$ | ( |
) | |
Adjustments to reconcile net loss to net cash used in operating activities: |
||||
Change in fair value of warrants |
||||
Loss on FPA liability |
||||
Compensation expense on Private Placement warrants |
||||
Offering costs allocated to warrant liabilities |
||||
Formation cost paid by Sponsor in exchange for issuance of founder shares |
||||
Operating expenses paid through advance from related party |
||||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
||||
Accrued expenses |
||||
Net cash used in operating activities |
( |
) | ||
Cash Flows from Investing Activities: |
||||
Investment of cash in Trust Account |
( |
) | ||
Net cash used in investing activities |
( |
) | ||
Cash Flows from Financing Activities: |
||||
Proceeds from sale of Units, net of underwriting discounts paid |
||||
Proceeds from sale of Private Placement Warrants |
||||
Repayment of advances from related party |
( |
) | ||
Net cash provided by financing activities |
||||
Net Change in Cash |
||||
Cash – Beginning |
||||
Cash – Ending |
$ |
|||
Non-Cash Investing and Financing Activities: |
||||
Offering costs paid directly by Sponsor from proceeds of issuance of Class B ordinary shares |
$ | |||
Accrued expenses paid through advances from related party |
$ | |||
Payment of offering costs through advances from related party |
$ | |||
Payment of prepaid expenses through advances from related party |
$ | |||
Initial classification of Class A ordinary shares subject to possible redemption |
$ | |||
Change in value of Class A ordinary shares subject to possible redemption |
$ | ( |
) | |
Deferred underwriting fee payable |
$ | |||
Initial classification of warrant liability: |
$ | |||
Initial classification of FPA liability: |
$ |
As Previously Reported |
Adjustments |
As Restated |
||||||||||
Balance sheet as of August 18, 2020 (audited) |
||||||||||||
Total Liabilities |
$ | $ | $ | |||||||||
Class A Ordinary Shares Subject to Redemption |
( |
) | ||||||||||
Class A Ordinary Shares |
||||||||||||
Additional Paid in Capital |
||||||||||||
Accumulated Deficit |
( |
) | ( |
) | ( |
) | ||||||
Number of Class A ordinary shares subject to redemption |
( |
) |
Balance sheet as of September 30, 2020 (unaudited) |
||||||||||||
Total Liabilities |
$ | $ | $ | |||||||||
Class A Ordinary Shares Subject to Redemption |
( |
) | ||||||||||
Class A Ordinary Shares |
||||||||||||
Additional Paid-in Capital |
||||||||||||
Accumulated Deficit |
( |
) | ( |
) | ( |
) | ||||||
Number of Class A ordinary shares subject to redemption |
( |
) |
Balance sheet as of December 31, 2020 (audited) |
||||||||||||
Total Liabilities |
$ | $ | $ | |||||||||
Class A Ordinary Shares Subject to Redemption |
( |
) | ||||||||||
Class A Ordinary Shares |
||||||||||||
Additional Paid-in Capital |
||||||||||||
Accumulated Deficit |
( |
) | ( |
) | ( |
) | ||||||
Number of Class A ordinary shares subject to redemption |
( |
) |
Statement of operations for the period from July 3, 2020 (inception) to September 30, 2020 (unaudited) |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Weighted average shares outstanding – Class A redeemable shares |
||||||||||||
Basic and Diluted EPS – Class A |
||||||||||||
Weighted average shares outstanding – Class B |
||||||||||||
Basic and Diluted EPS – Class B |
( |
) | ( |
) | ||||||||
Statement of operations for the period from July 3, 2020 (inception) to December 31, 2020 (audited) |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Weighted average shares outstanding – Class A redeemable shares |
||||||||||||
Basic and Diluted EPS – Class A |
||||||||||||
Weighted average shares outstanding – Class B |
||||||||||||
Basic and Diluted EPS – Class B |
( |
) | ( |
) | ( |
) |
For the Period from July 3, 2020 (inception) Through December 31, 2020 |
||||
Redeemable Class A Ordinary Shares |
||||
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares |
||||
Interest Income |
$ | |||
Net Earnings |
$ | |||
Denominator: Weighted Average Redeemable Class A Ordinary Shares |
||||
Redeemable Class A Ordinary Shares, Basic and Diluted |
||||
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares |
$ |
|||
Non-Redeemable Class B Ordinary Shares |
||||
Numerator: Net Loss minus Redeemable Net Earnings |
||||
Net Loss |
$ | ( |
) | |
Redeemable Net Earnings |
$ | |||
Non-Redeemable Net Loss |
$ |
( |
) | |
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares |
||||
Non-Redeemable Class B Ordinary Shares, Basic and Diluted |
||||
Loss/Basic and Diluted Non-Redeemable Class B Ordinary Shares |
$ |
( |
) | |
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Level |
December 31, 2020 |
|||||||
Liabilities: |
||||||||
Warrant Liability – Public Warrants |
1 | $ | ||||||
Warrant Liability – Private Placement Warrants |
3 | $ | ||||||
FPA Liability |
3 | $ |
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of July 3, 2020 (inception) |
$ | $ | $ | |||||||||
Initial measurement on August 18, 2020 |
||||||||||||
Change in valuation inputs or other assumptions |
||||||||||||
Fair value as of December 31, 2020 |
$ | $ | $ | |||||||||
FPA Liability |
||||
Fair value, July 3, 2020 |
$ | |||
Loss on change in fair value (1) |
||||
Fair value, December 31, 2020 |
$ | |||
(1) | Represents the non-cash loss on change in valuation of the FPA liability and is included in loss on change in fair value of FPA liability on the statement of operations. |
June 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
(Audited) |
|||||||
ASSETS |
||||||||
Current Assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
Total Current Assets |
||||||||
Investments held in Trust Account |
||||||||
Total Assets |
$ |
$ |
||||||
LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
||||||||
Current Liabilities: |
||||||||
Accounts payable and accrued expenses |
$ | $ | ||||||
Convertible note – related party, net of debt discount |
— | |||||||
Advances from related party |
||||||||
Total Current Liabilities |
||||||||
FPA liability |
||||||||
Conversion option on working capital loan liability |
— | |||||||
Warrant liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies |
||||||||
Class A ordinary shares subject to possible redemption, as of June 30, 2021 and December 31, 2020 at $ |
||||||||
Shareholders’ (Deficit) Equity |
||||||||
Preference shares, $ |
||||||||
Class A ordinary shares, $ as of June 30, December 31, 2020, respectively 2021 and |
||||||||
Class B ordinary shares, $ as of June 30, 2021 and December 31, 2020 |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Shareholders’ (Deficit) Equity |
( |
) | ||||||
Total Liabilities and Shareholders’ (Deficit) Equity |
$ |
$ |
||||||
Three Months Ended June 30, 2021 |
Six Months Ended June 30, 2021 |
|||||||
General and administrative expenses |
$ | $ | ||||||
|
|
|
|
|||||
Loss from operations |
( |
) |
( |
) | ||||
Other income (expense): |
||||||||
Interest earned on marketable securities held in Trust Account |
||||||||
Change in fair value of FPA liability |
||||||||
Change in fair value of conversion option on working capital loan |
( |
) | ( |
) | ||||
Change in fair value of warrant liabilities |
( |
) | ||||||
Interest expense - amortization of debt discount |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Other income (expense), net |
( |
) | ||||||
Net (loss) income |
$ |
( |
) |
$ |
||||
|
|
|
|
|||||
Weighted average shares outstanding of Class A ordinary redeemable shares |
||||||||
|
|
|
|
|||||
Basic and diluted income per share, Class A |
$ | $ | ||||||
|
|
|
|
|||||
Weighted average shares outstanding of Class B non-redeemable ordinary shares |
||||||||
|
|
|
|
|||||
Basic and diluted net loss per share, Class B non-redeemable ordinary shares |
$ |
( |
) |
$ |
||||
|
|
|
|
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in |
Accumulated |
Total Stockholders’ |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Equity (Deficit) |
||||||||||||||||||||||
Balance – January 1, 2021 |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||
Change in value of Class A Ordinary shares subject to possible redemption |
( |
) | ( |
) | — | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2021 |
( |
) |
( |
) | ||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – June 30, 2021 |
$ | $ |
$ | $ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Operating Activities: |
||||
Net income |
$ | |||
Adjustments to reconcile net income to net cash used in operating activities: |
||||
Change in fair value of warrant liabilities |
( |
) | ||
Change in fair value of FPA liability |
( |
) | ||
Change in fair value of conversion option on working capital loan |
||||
Amortization of debt discount |
||||
Interest earned on marketable securities held in Trust Account |
( |
) | ||
Changes in operating assets and liabilities: |
||||
Prepaid expenses |
||||
Accounts payable and accrued expenses |
||||
|
|
|||
Net cash (used in) operating activities |
( |
) | ||
|
|
|||
Cash Flows from Financing Activities: |
||||
Proceeds from convertible note - related party |
||||
Advances from related party |
||||
Repayment of advances from related party |
( |
) | ||
|
|
|||
Net cash provided by financing activities |
||||
|
|
|||
Net Change in Cash |
||||
Cash – Beginning |
||||
|
|
|||
Cash – Ending |
$ |
|||
|
|
|||
Non-Cash Investing and Financing Activities: |
||||
Initial classification of conversion option |
$ | |||
|
|
|||
Change in value of Class A ordinary shares subject to redemption |
$ | |||
|
|
Three Months Ended June, 30 |
Six Months Ended June 30, |
|||||||
2021 |
2021 |
|||||||
Redeemable Class A Ordinary Shares |
||||||||
Numerator: Earnings allocable to Redeemable Class A Ordinary Shares Interest Income earned on marketable securities held in Trust Account |
$ | $ | ||||||
Net Earnings |
$ | $ | ||||||
|
|
|
|
|||||
Denominator: Weighted Average Redeemable Class A Ordinary Shares Redeemable Class A Ordinary Shares, Basic and Diluted |
||||||||
|
|
|
|
|||||
Earnings/Basic and Diluted Redeemable Class A Ordinary Shares |
$ | $ | ||||||
|
|
|
|
|||||
Non-Redeemable Class B Ordinary Shares |
||||||||
Numerator: Net Income (Loss) minus Redeemable Net Earnings |
||||||||
Net Income (Loss) |
$ | ( |
) | $ | ||||
Redeemable Net Earnings |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Non-Redeemable Net Income (Loss) |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Denominator: Weighted Average Non-Redeemable Class B Ordinary Shares |
||||||||
Non-Redeemable Class B Ordinary Shares, Basic and Diluted |
||||||||
|
|
|
|
|||||
Earnings (loss)/Basic and Diluted Non-Redeemable Class B Ordinary Shares |
$ | ( |
) | $ | ||||
|
|
|
|
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Level |
June 30, 2021 |
December 31, 2020 |
||||||||||
Assets – Assets Held in Trust Account |
1 | $ | $ | |||||||||
Liabilities: |
||||||||||||
Warrant Liability – Public Warrants |
1 | $ | $ | |||||||||
Warrant Liability – Private Placement Warrants |
3 | $ | $ | |||||||||
Warrant Liability – Conversion option on working capital loan |
3 | $ | $ | |||||||||
FPA Liability |
2 | $ | $ |
Private Placement |
||||
Fair value as of January 1, 2021 |
$ | |||
Change in fair value |
( |
) | ||
|
|
|||
Fair value as of June 30, 2021 |
$ | |||
|
|
Conversion Option Liability |
||||
Fair value as of January 1, 2021 |
$ | |||
Initial classification of conversion option liability |
||||
Change in fair value |
( |
) | ||
|
|
|||
Fair value as of June 30, 2021 |
$ | |||
|
|
FPA Liability |
||||
Fair value as of January 1, 2021 |
$ | |||
Change in fair value |
( |
) | ||
|
|
|||
Fair value as of June 30, 2021 |
$ | |||
|
|
2020 |
2019 |
|||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable—Net of allowances of $ |
||||||||
Income taxes receivable |
||||||||
Deferred contract costs |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
SOFTWARE, EQUIPMENT, AND PROPERTY—Net |
||||||||
INTANGIBLE ASSETS—Net |
||||||||
GOODWILL |
||||||||
DEFERRED FINANCING FEES, REVOLVER—Net |
||||||||
DEFERRED CONTRACT COSTS |
||||||||
OTHER ASSETS |
||||||||
TOTAL |
$ | $ | ||||||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY |
||||||||
CURRENT LIABILITIES: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Income taxes payable |
||||||||
Current portion of long-term debt |
||||||||
Current portion of long-term licensing agreement—Net |
||||||||
Deferred revenues |
||||||||
Total current liabilities |
||||||||
LONG-TERM DEBT: |
||||||||
First Lien Term Loan—Net |
||||||||
Second Lien Term Loan—Net |
||||||||
Total long-term debt |
||||||||
DEFERRED INCOME TAXES—Net |
||||||||
LONG-TERM LICENSING AGREEMENT—Net |
||||||||
OTHER LIABILITIES |
||||||||
Total liabilities |
||||||||
COMMITMENTS AND CONTINGENCIES (Notes 18 and 19) |
||||||||
MEZZANINE EQUITY: |
||||||||
Redeemable non-controlling interests |
||||||||
STOCKHOLDERS’ EQUITY: |
||||||||
Preferred stock, $ |
||||||||
Common stock—Series A, $ |
||||||||
Common stock—Series B, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Total stockholders’ equity |
||||||||
TOTAL |
$ | $ | ||||||
2020 |
2019 |
2018 |
||||||||||
REVENUES |
$ | $ | $ | |||||||||
COST OF REVENUES |
||||||||||||
Cost of revenues, exclusive of amortization and impairment of acquired technologies |
||||||||||||
Amortization of acquired technologies |
||||||||||||
Impairment of acquired technologies |
||||||||||||
Total cost of revenues |
||||||||||||
GROSS MARGIN |
||||||||||||
OPERATING EXPENSES: |
||||||||||||
Research and development |
||||||||||||
Selling and marketing |
||||||||||||
General and administrative |
||||||||||||
Amortization of intangible assets |
||||||||||||
Impairment of goodwill |
||||||||||||
Impairment of intangible assets |
||||||||||||
Total operating expenses |
||||||||||||
OPERATING INCOME (LOSS) |
( |
) | ||||||||||
INTEREST EXPENSE |
( |
) | ( |
) | ( |
) | ||||||
(LOSS) GAIN ON CHANGE IN FAIR VALUE OF INTEREST RATE SWAPS |
( |
) | ( |
) | ||||||||
LOSS ON EARLY EXINGUISHMENT OF DEBT |
( |
) | ||||||||||
OTHER INCOME—Net |
||||||||||||
PRETAX LOSS |
( |
) | ( |
) | ( |
) | ||||||
INCOME TAX BENEFIT |
||||||||||||
NET LOSS INCLUDING NON-CONTROLLING INTEREST |
( |
) | ( |
) | ( |
) | ||||||
Less: net loss attributable to non-controlling interest |
||||||||||||
NET LOSS ATTRIBUTABLE TO CYPRESS HOLDINGS, INC. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Net loss per share attributable to Class A and Class B common stockholders - basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders - basic and diluted |
||||||||||||
COMPREHENSIVE LOSS: |
||||||||||||
Net loss including non-controlling interest |
( |
) | ( |
) | ( |
) | ||||||
Other comprehensive gain (loss)—Foreign currency translation adjustment |
( |
) | ( |
) | ||||||||
COMPREHENSIVE LOSS INCLUDING NON-CONTROLLING INTEREST |
( |
) | ( |
) | ( |
) | ||||||
Less: comprehensive loss attributable to non-controlling interest |
||||||||||||
COMPREHENSIVE LOSS ATTRIBUTABLE TO CYPRESS HOLDINGS, INC. |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Redeemable Non-Controlling Interest |
Issued Preferred Stock |
Issued Common Stock |
Additional Paid-In Capital |
Retained Earnings (Accumulated Deficit) |
Accumulated Other Comprehensive Loss |
|||||||||||||||||||||||||||||||||||||||
Series A |
Series B |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||
Number of Shares |
Par Value |
Number of Shares |
Par Value |
Number of Shares |
Par Value |
|||||||||||||||||||||||||||||||||||||||
BALANCE—January 1, 2018 |
$ | $ | |
$ | $ | |
$ | $ | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||
Dividend to shareholders |
— | — | — | — | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Exercise of stock options—net of tax |
— | — | — | — | — | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||||||||||
Repurchase and cancellation of Series B common stock |
— | — | — | — | — | ( |
) | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
BALANCE—December 31, 2018 |
( |
) | ||||||||||||||||||||||||||||||||||||||||||
Cumulative effect of change in accounting principle related to revenue recognition related to revenue recognition |
— | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Exercise of stock options—net of tax |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Repurchase and cancellation of Series B common stock |
— | — | — | — | — | ( |
) | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
BALANCE—December 31, 2019 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||
Issuance of non-controlling interest in subsidiary |
|
— | — | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||
Issuance of Series B common stock |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Exercise of stock options—net of tax |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
Repurchase and cancellation of Series B common stock |
— | — | — | — | — | ( |
) | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||
BALANCE—December 31, 2020 |
$ | — | $ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
2019 |
2018 |
||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Adjustments to reconcile net loss to net cash provid e d by operating activities: |
||||||||||||
Depreciation and amortization of software, equipment, and property |
||||||||||||
Amortization of intangible assets |
||||||||||||
Impairment of goodwill and intangible assets |
||||||||||||
Deferred income taxes |
( |
) | ( |
) | ( |
) | ||||||
Stock-based compensation |
||||||||||||
Amortization of deferred financing fees |
||||||||||||
Amortization of discount on debt |
||||||||||||
Change in fair value of interest rate swaps |
( |
) | ||||||||||
Loss on early extinguishment of debt |
||||||||||||
Gain on divestiture |
( |
) | ||||||||||
Other |
||||||||||||
Changes in: |
||||||||||||
Accounts receivable—Net |
( |
) | ( |
) | ||||||||
Deferred contract costs |
( |
) | ( |
) | ||||||||
Other current assets |
( |
) | ( |
) | ( |
) | ||||||
Deferred contract costs—Non-current |
( |
) | ( |
) | ||||||||
Other assets |
( |
) | ( |
) | ( |
) | ||||||
Income taxes |
( |
) | ( |
) | ||||||||
Accounts payable |
( |
) | ||||||||||
Accrued expenses |
( |
) | ||||||||||
Deferred revenues |
( |
) | ||||||||||
Other liabilities |
||||||||||||
|
|
|
|
|
|
|||||||
Net cash provided by operating activities |
||||||||||||
|
|
|
|
|
|
|||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||||||
Purchases of software, equipment, and property |
( |
) | ( |
) | ( |
) | ||||||
Purchase of intangible asset |
( |
) | ( |
) | ||||||||
Purchase of investment |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash used in investing activities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||||||
Proceeds from issuance of non-controlling interest in subsidiary |
||||||||||||
Principal payments on long-term debt |
( |
) | ( |
) | ( |
) | ||||||
Proceeds from issuance of long-term debt, net of fees paid to lender |
||||||||||||
Proceeds from borrowings on revolving lines of credit |
||||||||||||
Repayment of borrowings on revolving lines of credit |
( |
) | ||||||||||
Payment of fees associated with early extinguishment of long-term debt |
( |
) | ||||||||||
Proceeds from exercise of stock options |
||||||||||||
Repurchases of Series B common stock |
( |
) | ( |
) | ( |
) | ||||||
Dividend to stockholders |
( |
) | ||||||||||
|
|
|
|
|
|
|||||||
Net cash used in financing activities |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS |
( |
) | ( |
) | ||||||||
|
|
|
|
|
|
|||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
( |
) | ||||||||||
CASH AND CASH EQUIVALENTS: |
||||||||||||
Beginning of year |
||||||||||||
|
|
|
|
|
|
|||||||
End of year |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
NONCASH INVESTING AND FINANCING ACTIVITIES: |
||||||||||||
Unpaid liability related to software, equipment, and property |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Asset obtained in exchange for financing liability |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |
||||||||||||
Cash paid for interest |
$ | $ | $ | |||||||||
|
|
|
|
|
|
|||||||
Cash received (paid) for income taxes—Net |
$ | $ | ( |
) | $ | ( |
) | |||||
|
|
|
|
|
|
1. |
BASIS OF PRESENTATION AND NATURE OF OPERATIONS |
2. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Revenue |
||||||||||||
Year Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Customer A |
* | % | % | |||||||||
Customer B |
% | % | % |
Accounts Receivable |
||||||||
December 31, |
||||||||
2020 |
2019 |
|||||||
Customer A |
% | * | ||||||
Customer B |
* | % |
* | Below 10% |
• | Identification of the contract, or contracts, with a customer |
• | Identification of the performance obligation(s) in the contract |
• | Determination of the transaction price |
• | Allocation of the transaction price to the performance obligation(s) in the contract |
• | Recognition of revenue when, or as a performance obligation is satisfied |
2020 |
2019 |
2018 |
||||||||||
Software subscriptions |
$ | |
$ | |
$ | |
||||||
Other |
||||||||||||
|
|
|
|
|
|
|||||||
Total revenues |
$ | |
$ | |
$ | |
Software, equipment and property |
Estimated Useful Life |
|||||
|
|
|||||
Software and licenses | ||||||
Computer equipment | ||||||
Leasehold improvements | ||||||
Furniture and other equipment | ||||||
Database | ||||||
Building | ||||||
Land |
Balances without |
||||||||||||
As reported |
adoption of Topic 606 |
Effect of adoption |
||||||||||
Assets |
||||||||||||
Deferred contract costs |
$ | $ | — | $ | |
|||||||
Long-term deferred contract costs |
— | |||||||||||
Liabilities and stockholders’ equity |
||||||||||||
Deferred income taxes-net |
||||||||||||
Accumulated deficit |
( |
) | ( |
) |
Balances without |
||||||||||||
As reported |
adoption of Topic 606 |
Effect of adoption |
||||||||||
Revenues |
$ | $ | $ | — | ||||||||
Cost of revenues |
( |
) | ||||||||||
Selling and marketing |
( |
) | ||||||||||
Operating loss |
( |
) | ( |
) | ||||||||
Income tax benefit |
( |
) | ||||||||||
Net loss |
( |
) | ( |
) | ||||||||
Net loss per share attributable to Class A and Class B common stockholders - basic and diluted |
$ | ( |
) | $ | ( |
) | $ |
3. |
REVENUE |
December 31, 2020 |
December 31, 2019 |
January 1, 2019 |
||||||||||
Accounts receivables-Net of allowances |
$ | |
$ | |
$ | |
||||||
Deferred contract costs |
||||||||||||
Long-term deferred contract costs |
||||||||||||
Deferred revenues |
||||||||||||
Other liabilities (deferred revenues, non-current) |
2020 |
2019 |
|||||||
Balance at beginning of period |
$ | $ | ||||||
Revenue recognized 1 |
( |
) | ( |
) | ||||
Additional amounts deferred 1 |
||||||||
|
|
|
|
|||||
Balance at end of period |
$ | $ | ||||||
|
|
|
|
1 Amounts |
include total revenue deferred and recognized during each respective period. |
2020 |
2019 |
|||||||
Balance at beginning of period |
$ | $ | ||||||
Adoption of ASC 606 |
||||||||
Costs amortized |
( |
) | ( |
) | ||||
Additional amounts deferred |
||||||||
|
|
|
|
|||||
Balance at end of period |
$ | $ | |
|||||
|
|
|
|
|||||
Classified as: |
||||||||
Current |
$ | $ | ||||||
Non-current |
||||||||
|
|
|
|
|||||
Total deferred contract costs |
$ | $ | ||||||
|
|
|
|
4. |
FAIR VALUE MEASUREMENTS |
Liabilities |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Interest rate swaps |
$ | |
$ | |
$ | |
$ | |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | |
$ | |
$ | |
$ | |
Liabilities |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
Interest rate swaps |
$ | |
$ | |
$ | |
$ | |
||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
$ | |
$ | |
$ | |
$ | |
December 31, 2020 |
December 31, 2019 |
|||||||||||||||
Description |
Carrying Amount |
Estimated Fair Value |
Carrying Amount |
Estimated Fair Value |
||||||||||||
First Lien Term Loan, including current portion |
$ | |
$ | |
$ | |
$ | |
||||||||
Second Lien Term Loan |
5. |
INCOME TAXES |
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Domestic |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Foreign |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Pretax loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
Years Ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Current provision (benefit): |
||||||||||||
Federal |
$ | $ | $ | ( |
) | |||||||
State |
||||||||||||
|
|
|
|
|
|
|||||||
Total current provision |
||||||||||||
|
|
|
|
|
|
|||||||
Deferred provision (benefit): |
||||||||||||
Federal |
( |
) | ( |
) | ( |
) | ||||||
State |
( |
) | ( |
) | ||||||||
Foreign |
( |
) | ( |
) | ( |
) | ||||||
Change in valuation allowance |
||||||||||||
|
|
|
|
|
|
|||||||
Total deferred benefit |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Total income tax benefit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
|
|
|
|
|
|
Year Ended |
Year Ended |
Year Ended |
||||||||||||||||||||||
December 31, 2020 |
December 31, 2019 |
December 31, 2018 |
||||||||||||||||||||||
Federal income tax benefit at statutory rate |
$ | ( |
) | % | $ | ( |
) | % | $ | ( |
) | % | ||||||||||||
State and local taxes-net of federal income tax effect |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Impairment of goodwill |
— | — | ( |
) | — | — | ||||||||||||||||||
Foreign rate difference |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Research and experimental credit |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Other nondeductible expenses |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Uncertain tax positions |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Valuation allowance |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Other—net |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Income tax benefit |
$ | ( |
) | % | $ | ( |
) | % | $ | ( |
) | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
2019 |
|||||||
Deferred income tax assets: |
||||||||
Accrued compensation |
$ | $ | ||||||
Net operating losses—foreign |
||||||||
Stock-based compensation |
||||||||
Research and experimental credit |
||||||||
Sales allowances and doubtful accounts |
||||||||
Capitalized acquisition costs |
||||||||
Net operating losses—domestic (state) |
||||||||
Disallowed interest expense |
||||||||
Interest rate swaps |
||||||||
Other |
||||||||
|
|
|
|
|||||
Total deferred income tax assets |
||||||||
Valuation allowance for deferred tax asset |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net deferred income tax assets |
||||||||
|
|
|
|
|||||
Deferred income tax liabilities: |
||||||||
Intangible asset amortization |
||||||||
Software, equipment and property depreciation and amortization |
||||||||
Deferred contract costs |
||||||||
|
|
|
|
|||||
Total deferred income tax liabilities |
||||||||
|
|
|
|
|||||
Net deferred income tax liabilities |
$ | |
$ | |
||||
|
|
|
|
2020 |
2019 |
|||||||
Balance at beginning of year |
$ | $ | ||||||
Additions based on tax positions related to the current year |
||||||||
Additions based on true ups to tax positions of prior years |
||||||||
Reductions for tax positions of prior years |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Balance at end of year |
$ |
$ |
||||||
|
|
|
|
Jurisdiction |
Open Tax Years | |
US Federal |
||
US States |
||
China |
||
Canada |
6. |
ACCOUNTS RECEIVABLE |
2020 |
2019 |
|||||||
Accounts receivable |
$ | $ | ||||||
Allowance for doubtful accounts and sales reserves |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Accounts receivable–net |
$ | $ | ||||||
|
|
|
|
2020 |
2019 |
2018 |
||||||||||
Balance at beginning of period |
$ | $ | $ | |||||||||
Charges to bad debt and sales reserves |
||||||||||||
Write-offs, net |
( |
) | ( |
) | ( |
) | ||||||
|
|
|
|
|
|
|||||||
Balance at end of period |
$ | $ | $ | |||||||||
|
|
|
|
|
|
7. |
OTHER CURRENT ASSETS |
2020 |
2019 |
|||||||
Prepaid software and equipment maintenance |
$ | $ | ||||||
Prepaid SaaS costs |
||||||||
Prepaid service fees |
||||||||
Non-trade receivables |
||||||||
Other |
||||||||
|
|
|
|
|||||
Total |
$ | $ | ||||||
|
|
|
|
8. |
SOFTWARE, EQUIPMENT, AND PROPERTY |
2020 |
2019 |
|||||||
Software, licenses and database |
$ | $ | ||||||
Computer equipment |
||||||||
Leasehold improvements |
||||||||
Furniture and other equipment |
||||||||
Building and land |
||||||||
|
|
|
|
|||||
Total software, equipment, and property |
||||||||
Less accumulated depreciation and amortization |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Net software, equipment, and property |
$ | $ | ||||||
|
|
|
|
9. |
GOODWILL AND INTANGIBLE ASSETS |
Reconciliation of Goodwill carrying amount | Cost | Accumulated Impairment Loss |
Net Carrying Value |
|||||||||
Balance as of December 31, 2020 |
$ | $ | ( |
) | $ | |||||||
Balance as of December 31, 2019 |
( |
) |
2020 |
||||||||||||||||||||
Estimated Useful Life (Years) |
Weighted- Average Remaining Useful Life (Years) |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||||||||
Intangible assets: |
||||||||||||||||||||
Customer relationships |
$ | $ | ( |
) | $ | |||||||||||||||
Acquired technologies |
( |
) | ||||||||||||||||||
Favorable lease terms |
( |
) | ||||||||||||||||||
Subtotal |
( |
) | ||||||||||||||||||
Trademarks—indefinite life |
— | |||||||||||||||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||||||||||
2019 |
||||||||||||||||||||
Estimated Useful Life (Years) |
Weighted- Average Remaining Useful Life (Years) |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||||||||
Intangible assets: |
||||||||||||||||||||
Customer relationships |
$ | $ | ( |
) | $ | |||||||||||||||
Acquired technologies |
( |
) | ||||||||||||||||||
Favorable lease terms |
( |
) | ||||||||||||||||||
Subtotal |
( |
) | ||||||||||||||||||
Trademarks—indefinite life |
— | |||||||||||||||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||||||||||
Years Ending December 31 |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total |
$ | |||
10. |
ACCRUED EXPENSES |
2020 |
2019 |
|||||||
Compensation |
$ | $ | ||||||
Professional services |
||||||||
Royalties and licenses |
||||||||
Sales tax |
||||||||
Employee insurance benefits |
||||||||
Other |
||||||||
Total |
$ | $ | ||||||
11. |
OTHER LIABILITIES |
2020 |
2019 |
|||||||
Fair value of interest rate swaps |
$ | $ | ||||||
Deferred rent |
||||||||
Software license agreement |
||||||||
Deferred revenue-non-current |
||||||||
Phantom stock incentive plan |
||||||||
Payroll tax deferment |
— | |||||||
Other |
||||||||
Total |
$ | $ | ||||||
12. |
LONG-TERM DEBT |
2020 |
2019 |
|||||||
First Lien Term Loan |
$ | $ | ||||||
First Lien Term Loan—discount |
( |
) | ( |
) | ||||
First Lien Term Loan—deferred financing fees |
( |
) | ( |
) | ||||
First Lien Term Loan—net of discount & fees |
||||||||
Second Lien Term Loan |
— | |||||||
Second Lien Term Loan—discount |
— | ( |
) | |||||
Second Lien Term Loan—deferred financing fees |
— | ( |
) | |||||
Second Lien Term Loan—net of discount & fees |
— | |||||||
Total debt |
||||||||
Less: Current portion |
( |
) | ( |
) | ||||
Total long-term debt—net of current portion |
$ | $ | ||||||
Deferred Financing Fees |
Discount— Contra Debt |
|||||||
Balance—December 31, 2018 |
||||||||
Amortization of fees and discount |
( |
) | ( |
) | ||||
Balance—December 31, 2019 |
$ | $ | ||||||
Fees written off of due to early extinguishment of debt |
( |
) | ( |
) | ||||
Payment of fees and discount |
||||||||
Amortization of fees and discount |
( |
) | ( |
) | ||||
Balance—December 31, 2020 |
$ | $ | ||||||
Years Ending December 31 |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
Total |
$ | |||
13. |
LONG-TERM LICENSING AGREEMENT |
Years Ending December 31 |
||||
2021 |
||||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total |
$ | |||
14. |
REDEEMABLE NON-CONTROLLING INTEREST |
15. |
CAPITAL STOCK |
16. |
EMPLOYEE BENEFIT PLANS |
17. |
STOCK INCENTIVE PLANS |
• | an occurrence of a liquidity event related to the common stock (for example, sale of the Company or an initial public offering), |
• | the Company meets its private equity sponsors’ return target of at least 2 times their initial investment, and |
• | the employee is employed or the consultant is actively engaged by the Company. |
Year ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Expected term (in years) |
||||||||||||
Expected volatility |
% | % | % | |||||||||
Expected dividend yield |
% | % | % | |||||||||
Risk-free interest rate |
||||||||||||
Fair value at Valuation Date |
$ | $ | $ |
Year ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Expected term (in years) |
||||||||||||
Expected volatility |
% | % | % | |||||||||
Expected dividend yield |
% | % | % | |||||||||
Risk-free interest rate |
% | % | % | |||||||||
Fair value at Valuation Date |
$ | $ | $ |
Year ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Cost of Revenues |
$ | $ | $ | |||||||||
Research and development |
||||||||||||
Sales and marketing |
||||||||||||
General and administrative |
||||||||||||
Total share-based compensation expense |
$ | $ | $ | |||||||||
Shares |
Weighted- Average Exercise Price |
Weighted-Average Remaining Contractual Life (in years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Options outstanding—January 1, 2018 |
$ | |||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | ||||||||||||||
Forfeited and canceled |
( |
) | ||||||||||||||
Options outstanding—December 31, 2018 |
||||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | ||||||||||||||
Forfeited and canceled |
( |
) | ||||||||||||||
Shares |
Weighted- Average Exercise Price |
Weighted-Average Remaining Contractual Life (in years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Options outstanding—December 31, 2019 |
||||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | ||||||||||||||
Forfeited and canceled |
( |
) | ||||||||||||||
|
|
|||||||||||||||
Options outstanding—December 31, 2020 |
||||||||||||||||
|
|
|||||||||||||||
Options exercisable—December 31, 2020 |
||||||||||||||||
|
|
|||||||||||||||
Options vested and expected to vest—December 31, 2020 |
||||||||||||||||
|
|
18. |
COMMITMENTS |
2021 |
2022 |
2023 |
2024 |
2025 |
Thereafter |
Total |
||||||||||||||||||||||
Operating leases |
$ | $ | $ | $ | $ | $ | $ |
2021 |
2022 |
2023 |
2024 |
2025 |
Thereafter |
Total |
||||||||||||||||||||||
Purchase obligations |
$ | $ | $ | $ | $ | $ | $ |
19. |
LEGAL PROCEEDINGS AND CONTINGENCIES |
20. |
RELATED PARTIES |
21. |
NET LOSS PER SHARE |
Year ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
Numerator |
||||||||||||
Net loss |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
Denominator |
||||||||||||
Weighted average shares of common stock - basic and diluted |
||||||||||||
Net loss per share - basic and diluted |
$ | ( |
) | $ | ( |
) | $ | ( |
) |
22. |
SEGMENT INFORMATION AND INFORMATION ABOUT GEOGRAPHIC AREAS |
Year ended December 31, |
||||||||||||
2020 |
2019 |
2018 |
||||||||||
United States |
$ | $ | $ | |||||||||
China |
||||||||||||
Total revenues |
$ | $ | $ | |||||||||
December 31 |
||||||||
2020 |
2019 |
|||||||
United States |
$ | $ | ||||||
China |
||||||||
Total software, equipment and property-net |
$ | $ | ||||||
23. |
DIVESTITURE |
24. |
SUBSEQUENT EVENTS |
June 30, 2021 (Unaudited) |
December 31, 2020 |
|||||||
ASSETS |
||||||||
CURRENT ASSETS: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Accounts receivable—Net of allowances of $ |
||||||||
Income taxes receivable |
||||||||
Deferred contract costs |
||||||||
Other current assets |
||||||||
Total current assets |
||||||||
SOFTWARE, EQUIPMENT, AND PROPERTY—Net |
||||||||
OPERATING LEASE ASSETS |
— | |||||||
INTANGIBLE ASSETS—Net |
||||||||
GOODWILL |
||||||||
DEFERRED FINANCING FEES, REVOLVER—Net |
||||||||
DEFERRED CONTRACT COSTS |
||||||||
EQUITY METHOD INVESTMENT |
— | |||||||
OTHER ASSETS |
||||||||
TOTAL |
$ | $ | ||||||
LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY |
||||||||
CURRENT LIABILITIES: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Income taxes payable |
||||||||
Current portion of long-term debt |
||||||||
Current portion of long-term licensing agreement—Net |
||||||||
Operating lease liabilities |
— | |||||||
Deferred revenues |
||||||||
Interest rate swap derivatives |
— | |||||||
Total current liabilities |
||||||||
FIRST LIEN TERM LOAN—Net |
||||||||
DEFERRED INCOME TAXES—Net |
||||||||
LONG-TERM LICENSING AGREEMENT—Net |
||||||||
OPERATING LEASE LIABILITIES |
— | |||||||
OTHER LIABILITIES |
||||||||
Total liabilities |
||||||||
COMMITMENTS AND CONTINGENCIES (Notes 20 and 21) |
||||||||
MEZZANINE EQUITY: |
||||||||
Redeemable non-controlling interest |
||||||||
STOCKHOLDERS’ EQUITY: |
||||||||
Preferred stock, $ |
||||||||
Common stock—Series A, $ |
June 30, 2021 (Unaudited) |
December 31, 2020 |
|||||||
Common stock—Series B, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Accumulated other comprehensive loss |
( |
) | ( |
) | ||||
Total stockholders’ equity |
||||||||
TOTAL |
$ | $ | ||||||
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
REVENUES |
$ | $ | $ | $ | ||||||||||||
COST OF REVENUES |
||||||||||||||||
Cost of revenues, exclusive of amortization of acquired technologies |
||||||||||||||||
Amortization of acquired technologies |
||||||||||||||||
Total cost of revenues |
||||||||||||||||
GROSS PROFIT |
||||||||||||||||
OPERATING EXPENSES: |
||||||||||||||||
Research and development |
||||||||||||||||
Selling and marketing |
||||||||||||||||
General and administrative |
||||||||||||||||
Amortization of intangible assets |
||||||||||||||||
Total operating expenses |
||||||||||||||||
OPERATING INCOME |
||||||||||||||||
INTEREST EXPENSE |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
GAIN (LOSS) ON CHANGE IN FAIR VALUE OF INTEREST RATE SWAPS |
( |
) | ||||||||||||||
LOSS ON EARLY EXINGUISHMENT OF DEBT |
( |
) | ||||||||||||||
OTHER INCOME—Net |
||||||||||||||||
PRETAX INCOME (LOSS) |
( |
) | ( |
) | ( |
) | ||||||||||
INCOME TAX (PROVISION) BENEFIT |
( |
) | ||||||||||||||
NET INCOME (LOSS) INCLUDING NON-CONTROLLING INTEREST |
( |
) | ( |
) | ( |
) | ||||||||||
Less: net income (loss) attributable to non-controlling interest |
||||||||||||||||
NET INCOME (LOSS) ATTRIBUTABLE TO CYPRESS HOLDINGS, INC. |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Net income (loss) per share attributable to Class A and Class B common stockholders: |
||||||||||||||||
Basic |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Diluted |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Weighted-average shares used in computing net income (loss) per share attributable to Class A and Class B common stockholders: |
||||||||||||||||
Basic |
||||||||||||||||
Diluted |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
COMPREHENSIVE INCOME (LOSS): |
||||||||||||||||
Net income (loss) including non-controlling interest |
( |
) | ( |
) | ( |
) | ||||||||||
Other comprehensive loss—Foreign currency translation adjustment |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
COMPREHENSIVE INCOME (LOSS) INCLUDING NON-CONTROLLING INTEREST |
( |
) | ( |
) | ( |
) | ||||||||||
Less: comprehensive income (loss) attributable to non-controlling interest |
||||||||||||||||
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CYPRESS HOLDINGS, INC. |
$ |
|
|
$ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Redeemable Non-Controlling Interest |
Additional Paid-In Capital |
Retained Earnings (Accumulated Deficit) |
Accumulated Other Comprehensive Loss |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Issued Preferred Stock |
Issued Common Stock |
|||||||||||||||||||||||||||||||||||||||||||||||
Series A |
Series B |
|||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares |
Par Value |
Number of Shares |
Par Value |
Number of Shares |
Par Value |
|||||||||||||||||||||||||||||||||||||||||||
BALANCE—December 31, 2020 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||||||||||||||||||||||
Issuance of Series B common stock |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Exercise of stock options—net of tax |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Dividend to shareholders |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||
BALANCE—March 31, 2021 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
BALANCE—June 30, 2021 |
$ | $ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||||||
Redeemable Non-Controlling Interest |
Additional Paid-In Capital |
Retained Earnings (Accumulated Deficit) |
Accumulated Other Comprehensive Loss |
Total Stockholders’ Equity |
||||||||||||||||||||||||||||||||||||||||||||
Issued Preferred Stock |
Issued Common Stock |
|||||||||||||||||||||||||||||||||||||||||||||||
Series A |
Series B |
|||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares |
Par Value |
Number of Shares |
Par Value |
Number of Shares |
Par Value |
|||||||||||||||||||||||||||||||||||||||||||
BALANCE—December 31, 2019 |
$ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | |||||||||||||||||||||||||||||||||||||
Issuance of non-controlling interest in subsidiary |
— | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||
Issuance of Series B common stock |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Exercise of stock options—net of tax |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Repurchase and cancellation of Series B common stock |
— | — | — | — | — | ( |
) | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||
BALANCE—March 31, 2020 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
Stock-based compensation expense |
— | — | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||
Exercise of stock options—net of tax |
— | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||||||
Repurchase and cancellation of Series B common stock |
— | — | — | — | — | ( |
) | — | ( |
) | — | — | ( |
) | ||||||||||||||||||||||||||||||||||
Foreign currency translation adjustment |
— | — | — | — | — | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||||||||||||
BALANCE—June 30, 2020 |
$ | $ | $ | $ | $ | $ | ( |
) | $ | ( |
) | $ | ||||||||||||||||||||||||||||||||||||
For the Six Months Ended June 30, |
||||||||
2021 |
2020 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
||||||||
Net loss |
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to net cash provided by operating activities: |
||||||||
Depreciation and amortization of software, equipment, and property |
||||||||
Amortization of intangible assets |
||||||||
Deferred income taxes |
( |
) | ( |
) | ||||
Stock-based compensation |
||||||||
Amortization of deferred financing fees |
||||||||
Amortization of discount on debt |
||||||||
Change in fair value of interest rate swaps |
( |
) | ||||||
Loss on early extinguishment of debt |
||||||||
Non-cash lease expense |
||||||||
Other |
||||||||
Changes in: |
||||||||
Accounts receivable—Net |
( |
) | ( |
) | ||||
Deferred contract costs |
( |
) | ||||||
Other current assets |
( |
) | ||||||
Deferred contract costs—Non-current |
( |
) | ( |
) | ||||
Other assets |
( |
) | ||||||
Operating lease assets |
||||||||
Income taxes |
( |
) | ||||||
Accounts payable |
( |
) | ||||||
Accrued expenses |
( |
) | ||||||
Operating lease liabilities |
( |
) | ||||||
Deferred revenues |
||||||||
Other liabilities |
( |
) | ( |
) | ||||
Net cash provided by operating activities |
||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
||||||||
Purchases of software, equipment, and property |
( |
) | ( |
) | ||||
Purchase of equity method investment |
( |
) | ||||||
Purchase of intangible asset |
( |
) | ( |
) | ||||
Net cash used in investing activities |
( |
) | ( |
) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
||||||||
Proceeds from issuance of non-controlling interest in subsidiary |
||||||||
Principal payments on long-term debt |
( |
) | ( |
) | ||||
Proceeds from issuance of long-term debt, net of fees paid to lender |
||||||||
Proceeds from borrowings on revolving lines of credit |
||||||||
Repayment of borrowings on revolving lines of credit |
( |
) | ||||||
Proceeds from issuance of Series B common stock |
||||||||
Payment of fees associated with early extinguishment of long-term debt |
( |
) | ||||||
Proceeds from exercise of stock options |
||||||||
Repurchases of Series B common stock |
( |
) | ||||||
Dividend to stockholders |
( |
) | ||||||
Net cash used in financing activities |
( |
) | ||||||
For the Six Months Ended June 30, |
||||||||
2021 |
2020 |
|||||||
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS |
( |
) | ( |
) | ||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
( |
) | ||||||
CASH AND CASH EQUIVALENTS: |
||||||||
Beginning of period |
||||||||
End of period |
$ | $ |
|
| ||||
NONCASH INVESTING AND FINANCING ACTIVITIES: |
||||||||
Unpaid liability related to software, equipment, and property |
$ | $ | ||||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: |
||||||||
Cash paid for interest |
$ | $ | ||||||
Cash received (paid) for income taxes—Net |
$ | ( |
) | $ | ||||
1. |
BASIS OF PRESENTATION AND NATURE OF OPERATIONS |
2. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Customer A |
* | * | * | * | ||||||||||||
Customer B |
* | % | * | % |
* | Below 10% |
June 30, 2021 |
December 31, 2020 |
|||||||
Customer A |
% | % | ||||||
Customer B |
% | * |
* | Below 10% |
• | Identification of the contract, or contracts, with a customer |
• | Identification of the performance obligation(s) in the contract |
• | Determination of the transaction price |
• | Allocation of the transaction price to the performance obligation(s) in the contract |
• | Recognition of revenue when, or as a performance obligation is satisfied |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Software subscriptions |
$ | $ | $ | $ | ||||||||||||
Other |
||||||||||||||||
Total revenues |
$ | $ | $ | $ | ||||||||||||
Software, equipment, and property |
Estimated Useful Life |
|||
Software and licenses |
||||
Computer equipment |
||||
Leasehold improvements |
||||
Furniture and other equipment |
||||
Database |
||||
Building |
||||
Land |
3. |
REVENUE |
June 30, 2021 |
December 31, 2020 |
|||||||
Accounts receivables-Net of allowances |
$ | $ | ||||||
Deferred contract costs |
||||||||
Long-term deferred contract costs |
||||||||
Deferred revenues |
||||||||
Other liabilities (deferred revenues, non-current) |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Balance at beginning of period |
$ | $ | $ | $ | ||||||||||||
Revenue recognized 1 |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Additional amounts deferred 1 |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at end of period |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
1 |
Amounts include total revenue deferred and recognized during each respective period. |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Balance at beginning of period |
$ | $ | $ | $ | ||||||||||||
Costs amortized |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Additional amounts deferred |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at end of period |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Classified as: |
||||||||||||||||
Current |
$ | $ | $ | $ | ||||||||||||
Non-current |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total deferred contract costs |
$ | $ | $ | $ | ||||||||||||
|
|
|
|
|
|
|
|
4. |
FAIR VALUE MEASUREMENTS |
Fair Value |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||
Liabilities |
||||||||||||||||
Interest rate swaps |
$ | $ | $ | $ | ||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
Fair Value |
Level 1 |
Level 2 |
Level 3 |
|||||||||||||
Liabilities |
||||||||||||||||
Interest rate swaps |
$ | $ | $ | $ | ||||||||||||
Total |
$ | $ | $ | $ | ||||||||||||
June 30, 2021 |
December 31, 2020 |
|||||||||||||||
Carrying Amount |
Estimated Fair Value |
Carrying Amount |
Estimated Fair Value |
|||||||||||||
First Lien Term Loan, including current portion |
$ | $ | $ | $ |
5. |
INCOME TAXES |
6. |
ACCOUNTS RECEIVABLE |
June 30, 2021 |
December 31, 2020 |
|||||||
Accounts receivable |
$ | $ | ||||||
Allowance for doubtful accounts and sales reserves |
( |
) | ( |
) | ||||
Accounts receivable–net |
$ | $ | ||||||
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Balance at beginning of period |
$ | $ | $ | $ | ||||||||||||
Charges to bad debt and sales reserves |
||||||||||||||||
Write-offs, net |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Balance at end of period |
$ | $ | $ | $ | ||||||||||||
7. |
OTHER CURRENT ASSETS |
June 30, 2021 |
December 31, 2020 |
|||||||
Prepaid software and equipment maintenance |
$ | $ | ||||||
Prepaid SaaS costs |
||||||||
Prepaid service fees |
||||||||
Non-trade receivables |
||||||||
Deferred business combination costs |
||||||||
Other |
||||||||
Total |
$ | $ | ||||||
8. |
SOFTWARE, EQUIPMENT, AND PROPERTY |
June 30, 2021 |
December 31, 2020 |
|||||||
Software, licenses and database |
$ | $ | ||||||
Computer equipment |
||||||||
Leasehold improvements |
||||||||
Furniture and other equipment |
||||||||
Building and land |
||||||||
Total software, equipment, and property |
||||||||
Less accumulated depreciation and amortization |
( |
) | ( |
) | ||||
Net software, equipment, and property |
$ | $ | ||||||
9. |
LEASES |
For the Three Months Ended June 30, 2021 |
For the Six Months Ended June 30, 2021 |
|||||||
Operating lease costs |
$ | $ | ||||||
Variable lease costs |
||||||||
Total lease costs |
$ | $ | ||||||
Weighted-average remaining lease term (years) |
||||
Weighted-average discount rate |
% |
For the Three Months Ended June 30, 2021 |
For the Six Months Ended June 30, 2021 |
|||||||
Cash payments for operating leases |
$ | $ | ||||||
Operating lease assets obtained in exchange for lease liabilities |
Years Ending December 31: |
||||
Remainder of 2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total Lease Payments |
||||
Less: Interest |
( |
) | ||
Less: Lease incentive recognized as offset to lease liability |
( |
) | ||
Total |
$ | |||
Years Ending December 31: |
||||
2021 |
$ | |||
2022 |
||||
2023 |
||||
2024 |
||||
2025 |
||||
Thereafter |
||||
Total |
$ | |||
10. |
GOODWILL AND INTANGIBLE ASSETS |
Estimated Useful Life (Years) |
Weighted- Average Remaining Useful Life (Years) |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||||||||
Intangible assets: |
||||||||||||||||||||
Customer relationships |
$ | $ | ( |
) | $ | |||||||||||||||
Acquired technologies |
( |
) | ||||||||||||||||||
Favorable lease terms |
( |
) | ||||||||||||||||||
Subtotal |
( |
) | ||||||||||||||||||
Trademarks—indefinite life |
— | |||||||||||||||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||||||||||
Estimated Useful Life (Years) |
Weighted- Average Remaining Useful Life (Years) |
Gross Carrying Amount |
Accumulated Amortization |
Net Carrying Amount |
||||||||||||||||
Intangible assets: |
||||||||||||||||||||
Customer relationships |
$ | $ | ( |
) | $ | |||||||||||||||
Acquired technologies |
( |
) | ||||||||||||||||||
Favorable lease terms |
( |
) | ||||||||||||||||||
Subtotal |
( |
) | ||||||||||||||||||
Trademarks—indefinite life |
— | |||||||||||||||||||
Total intangible assets |
$ | $ | ( |
) | $ | |||||||||||||||
Years Ending December 31: |
||||
2021 | $ | |||
2022 | ||||
2023 | ||||
2024 | ||||
2025 | ||||
Thereafter | ||||
Total | $ | |||
11. |
EQUITY METHOD INVESTMENT |
Equity Method Investment |
||||
Equity method investment carrying value at December 31, 2020 |
$ | |||
Cash contributions |
||||
Share of net income (loss) from the Investee |
— | |||
Equity method investment carrying value at June 30, 2021 |
$ | |||
12. |
ACCRUED EXPENSES |
June 30, 2021 |
December 31, 2020 |
|||||||
Compensation | $ | $ | ||||||
Professional services | ||||||||
Royalties and licenses | ||||||||
Sales tax | ||||||||
Employee insurance benefits | ||||||||
Software license agreement | — | |||||||
Other | ||||||||
Total | $ | $ | ||||||
13. |
OTHER LIABILITIES |
June 30, 2021 |
December 31, 2020 |
|||||||
Phantom stock incentive plan |
$ | $ | ||||||
Payroll tax deferment |
||||||||
Software license agreement |
||||||||
Deferred revenue-non-current |
||||||||
Deferred rent |
— | |||||||
Fair value of interest rate swaps |
— | |||||||
Other |
||||||||
Total |
$ | $ | ||||||
14. |
LONG-TERM DEBT |
June 30, 2021 |
December 31, 2020 |
|||||||
First Lien Term Loan |
$ | $ | ||||||
First Lien Term Loan—discount |
( |
) | ( |
) | ||||
First Lien Term Loan—deferred financing fees |
( |
) | ( |
) | ||||
First Lien Term Loan—net of discount & fees |
||||||||
Less: Current portion |
( |
) | ( |
) | ||||
Total long-term debt—net of current portion |
$ | $ | ||||||
15. |
LONG-TERM LICENSING AGREEMENT |
16. |
REDEEMABLE NON-CONTROLLING INTEREST |
17. |
CAPITAL STOCK |
18. |
EMPLOYEE BENEFIT PLANS |
19. |
STOCK INCENTIVE PLANS |
• | an occurrence of a liquidity event related to the common stock (for example, sale of the Company or an initial public offering), |
• | the Company meets its principal equity owners’ return target of at least 2 times their initial investment, and |
• | the employee is employed or the consultant is actively engaged by the Company. |
Expected term (in years) |
||||
Expected volatility |
% | |||
Expected dividend yield |
% | |||
Risk-free interest rate |
% | |||
Fair value at valuation date |
$ |
Expected term (in years) |
||||
Expected volatility |
% | |||
Expected dividend yield |
% | |||
Risk-free interest rate |
% | |||
Fair value at valuation date |
$ |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Cost of revenues |
$ | $ | $ | $ | ||||||||||||
Research and development |
||||||||||||||||
Sales and marketing |
||||||||||||||||
General and administrative |
||||||||||||||||
Total stock-based compensation expense |
$ | $ | $ | $ | ||||||||||||
Shares |
Weighted- Average Exercise Price |
Weighted-Average Remaining Contractual Life (in years) |
Aggregate Intrinsic Value (in thousands) |
|||||||||||||
Options outstanding—December 31, 2020 |
||||||||||||||||
Granted |
||||||||||||||||
Exercised |
( |
) | ||||||||||||||
Forfeited and canceled |
( |
) | ||||||||||||||
Options outstanding—June 30, 2021 |
||||||||||||||||
Options exercisable—June 30, 2021 |
||||||||||||||||
Options vested and expected to vest—June 30, 2021 |
||||||||||||||||
20. |
COMMITMENTS |
21. |
LEGAL PROCEEDINGS AND CONTINGENCIES |
22. |
RELATED PARTIES |
23. |
NET INCOME (LOSS) PER SHARE |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Numerator |
||||||||||||||||
Net income (loss) |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Denominator |
||||||||||||||||
Weighted average shares of common stock - basic |
||||||||||||||||
Dilutive effect of stock options |
||||||||||||||||
Weighted average shares of common stock - diluted |
||||||||||||||||
Net income (loss) per share: |
||||||||||||||||
Basic |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||||
Diluted |
$ | $ | ( |
) | $ | ( |
) | $ | ( |
) |
24. |
SEGMENT INFORMATION AND INFORMATION ABOUT GEOGRAPHIC AREAS |
For the Three Months Ended June 30, |
For the Six Months Ended June 30, |
|||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
United States |
$ | $ | $ | $ | ||||||||||||
China |
||||||||||||||||
Total revenues |
$ | $ | $ | $ | ||||||||||||
June 30, 2021 |
December 31, 2020 |
|||||||
United States |
$ | $ | ||||||
China |
||||||||
Total software, equipment and property-net |
$ | $ | ||||||
25. |
DIVESTITURE |
26. |
SUBSEQUENT EVENTS |
Amount Paid or to be Paid |
||||
SEC Registration Fee |
$ | 649,215.32 | ||
Printing |
125,000 | |||
Legal fees and expenses |
150,000 | |||
Accounting fees and expenses |
175,000 | |||
Miscellaneous expenses |
10,000 | |||
|
|
|||
Total: |
$ | 1,109,215.32 | ||
|
|
* | Filed herewith. |
** | Previously filed. |
+ | Indicates a management or compensatory plan. |
† | Schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Registration S-K. The Registrant hereby agrees to furnish a copy of any omitted schedules to the Commission upon request. |
CCC Intelligent Solutions Holdings Inc. | ||
By: | /s/ Githesh Ramamurthy | |
Name: | Githesh Ramamurthy | |
Title: | Chief Executive Officer and Chairman of the Board of Directors |
Signature |
Title |
Date | ||
/s/ Githesh Ramamurthy |
Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) |
September 3, 2021 | ||
Githesh Ramamurthy | ||||
/s/ Brian Herb |
Executive Vice President, Chief Financial and Administrative Officer (Principal Financial Officer) | September 3, 2021 | ||
Brian Herb | ||||
/s/ Rodney Christo |
Chief Accounting Officer (Principal Accounting Officer) |
September 3, 2021 | ||
Rodney Christo | ||||
* |
Director | September 3, 2021 | ||
Steven G. Puccinelli |
||||
* |
Director | September 3, 2021 | ||
William Ingram | ||||
* |
Director | September 3, 2021 | ||
David Yuan |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Prospectus constituting a part of this Registration Statement on Amendment No. 1 to Form S-1 of our report dated May 13, 2021, relating to the financial statements of Dragoneer Growth Opportunities Corp., which is contained in that Prospectus. We also consent to the reference to our Firm under the caption Experts in the Prospectus.
/s/ WithumSmith+Brown, PC |
|
|||
New York, New York |
||||
September 3, 2021 |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement No. 333-259142 on Form S-1 of our report dated March 29, 2021, relating to the financial statements of Cypress Holdings, Inc. We also consent to the reference to us under the heading Experts in such Registration Statement.
/s/ Deloitte & Touche LLP
Chicago, IL
September 3, 2021